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ABSTRACT
Examining Stage at Diagnosis and Survival in Three Cancers with Definitive Screening Guidelines
for Average-risk Adults: The Role of Marital Status
by
David John Blackley
Each year there are more than 350 000 new cases and nearly 100 000 deaths attributed to
colorectal, female breast, and cervical cancer in the United States. Screening tests can reduce
morbidity and mortality associated with these cancers. Patient marital status has been
associated with health outcomes, but no study has focused on the relationship of marriage with
disease stage and survival for the 3 cancers with established screening guidance. It is critical to
identify special populations that may be at risk for poor cancer outcomes.
The objective of this study was to examine the relationship of marital status with disease stage
at the time of diagnosis and cancer-specific survival among population-based cohorts of
patients diagnosed with invasive colorectal, breast, or cervical cancers. Subjects came from
states or regions reporting to the Surveillance, Epidemiology, and End Results (SEER) tumor
registries. The study included more than 243 500 patients diagnosed between January 1st 2004
and December 31st 2006 with 1 of these 3 cancers and who were followed for a minimum of 3
years. Descriptive statistics were calculated to summarize patient demographic and clinical
characteristics. Baseline category logit models were fit to evaluate the association between
marital status and disease stage. Kaplan-Meier survival curves and Cox proportional hazards
models were developed to evaluate differences in patient survival across 4 marital status
categories.
2

Married adults with colorectal, breast, and cervical cancer were diagnosed at an earlier disease
stage than those who were divorced/separated, widowed, or single. After controlling for stage
and demographic factors, married patients also experienced superior cancer-specific survival
(range: 19-33% better) as compared to those in non-married groups.
Divorced/separated, widowed, and single adults are a subset of the population that may
benefit from targeted prevention or care initiatives for cancers than can be detected early.
Social support networks, selection effects, or other causal mechanisms likely moderate the
protective association observed between marriage and cancer outcomes. These findings
characterize a meaningful disparity in health outcomes. Additional person-level data on
preventive health behaviors and treatment decisions could help solidify understanding of the
issue and improve the ability to design effective research, interventions, and policy.
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CHAPTER 1
INTRODUCTION
Burden of Cancer in the United States
Cancer is an ongoing public health problem in the United States (U.S.), and it is the
second leading cause of death after heart disease. According to most recent estimates, there
are about 1 640 000 new cancer cases and 577 000 cancer deaths in the U.S. each year.1
Approximately 1 of every 4 deaths in the U.S. is a result of cancer, but it has been estimated
that approximately one-third of these premature deaths could be avoided with proper
adherence to screening recommendations.2 Among males, lung/bronchus, prostate, and
colorectal cancers account for about half of all incident cases; among females, lung/bronchus,
breast, and colorectal cancers make up half of new cases.1 Within the U.S. population, these 4
cancers account for about half of all deaths attributed to cancer, with lung cancer the leading
cause of cancer death in males and females. Forty-five percent of males and 38% of females
will be diagnosed with invasive cancer at some point in their lives, but females have a slightly
higher likelihood than males of developing cancer before age 60 years due to breast cancer’s
tendency to be diagnosed at an earlier age relative to other cancer types.1
The U.S. population is likely experiencing its first sustained decline in overall cancer
mortality since the 1930s. Among the U.S. male population, overall cancer incidence declined
by an average of 0.6% per year between 1994 and 2008; an annual decline of 0.5% was
observed among females until 2006, at which point the rate of decline moderated through
2008.3 All-cancer mortality rates for both males and females appear to have peaked in the
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early 1990s, and data suggest the annual decline in overall death rate was approximately 1.5%
for both sexes from 2004 through 2008.1,3 These decreases in the overall cancer death rate are
likely a result of a variety of clinical and public health interventions and initiatives applied
across the cancer continuum, including improvements in primary prevention, screening and
treatment.3 Incidence rates for 3 of the 4 leading tumor sites mentioned above have declined
in recent years, with the lone exception being female breast cancer (Figures 1 and 2).4
Research has linked changes in invasive female breast cancer incidence rates with variations in
reproductive risk factors, mammography uptake and the prevalence of hormone replacement
therapy among women.3

Figure 1: Age-adjusted incidence rates, lung/bronchus, prostate, and colorectal cancers
diagnosed in males, all ages, United States, 2003 through 2009
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Figure 2: Age-adjusted incidence rates, lung/bronchus, breast, and colorectal cancers diagnosed
in females, all ages, United States, 2003 through 2009
Reductions in lung cancer incidence are associated with historical declines in smoking
prevalence, and declines in colorectal cancer incidence are partially attributed to improved
uptake of endoscopic and radiologic screening methods capable of detecting, and then
removing, precancerous growths.5 Mortality rates for lung/bronchus, breast, colorectal, and
prostate cancers are all decreasing (Figures 3 and 4), with reductions in lung cancer deaths
accounting for 34%-40% of the overall decline, with slight variation by sex.1,6 Among women
substantial reductions in breast and colorectal cancer death rates account for more than half of
the reduction in overall cancer mortality observed in recent years.5,7 Among young men
leukemia is the most common cause of cancer death, with lung cancer the leading cause after
age 40 years. In women leukemia is the leading cause of cancer death until age 20 years, breast
cancer between 21 and 59 years, and lung cancer after age 60 years.1
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Figure 3: Age-adjusted mortality rates, lung/bronchus, prostate, and colorectal cancers
diagnosed in males, all ages, United States, 2003 through 2009

Figure 4: Age-adjusted mortality rates, lung/bronchus, breast, and colorectal cancers diagnosed
in females, all ages, United States, 2003 through 2009
Cancer Disparities in the United States
There are large regional differences in overall cancer incidence and mortality in the U.S.,
and of the major tumor types, lung cancer has the most notable geographic variation.1,8
14

Regional variations are less pronounced for other tumor types, and for cancer that can be
detected early, state-to-state differences in incidence and mortality usually reflect variations in
screening uptake, although this doesn’t entirely explain variations in rates.1 In addition to
region of residence, race/ethnicity is also associated with differences in population cancer
outcomes. In the U.S. black men are 15% more likely than white men to get cancer, and 33%
more likely to die from it; black women are 6% less likely than white women to get cancer, but
16% more likely to die from it.1 Factors potentially contributing to disparities along racial lines
vary by cancer type but may include differences in risk factor exposures, screening access, and
timely and appropriate diagnosis and treatment.9 Cancer incidence and mortality among
smaller minority groups in the U.S. is lower than in non-Hispanic whites and blacks for most
cancer types, with the exception of those frequently associated with infectious agents, such as
cancers of the cervix, stomach, and liver.1
For lung/bronchus, prostate, colorectal, and breast cancers combined, African
Americans are more likely than non-Hispanic whites to have regional or distant stage disease at
diagnosis, most likely predisposing this minority group to a poorer prognosis before treatment
can even be initiated.10 For nearly every cancer type, 5-year survival is lower among African
Americans than non-Hispanic whites independent of stage at diagnosis, which may be
explained by racial disparities in access to care or differences in the presence of comorbidities
and/or behavioral risk factors. Although disparities remain, both African Americans and whites
have experienced marked improvements in 5-year cancer survival since 1975, which are likely a
result of improved early detection and more effective cancer-directed treatments.1 Two
prominent cancers that have shown little-to-no improvement in 5-year survival rates in recent
15

years are lung/bronchus and pancreatic cancers, neither of which has widely accepted early
detection methods.
Significance of Research
Survival following a cancer diagnosis largely depends on intrinsic tumor characteristics;
however, socioeconomic, cultural, and demographic factors may also influence survival to
varying degrees.11 For cancers with definitive, evidence-based screening recommendations, it
is critical for researchers and clinicians to be able to identify populations that may be at risk for
presentation with advanced tumor stage and lower survival relative to the general population.
National expert panels clearly recommend and provide evidence-based guidance for screening
among average-risk adults for colorectal cancer, female breast cancer, and cervical cancer.
These recommendations are based on peer-reviewed science demonstrating that proper
screening for these cancers reduces morbidity and mortality.12 The primary goal of this
dissertation is to examine the association of patient marital status with tumor stage at
diagnosis and survival for the 3 cancer types that have well established screening
recommendations for the average-risk population. Research has identified an association
between marital status and survival for multiple types of cancer, but results have not been
entirely consistent. Given the dynamic nature of the institution of marriage (and its varying
connotations and inherent responsibilities, depending on country of residence), many past
findings may not be generalizable to the contemporary U.S. general population, because many
of the studies were conducted in Europe and most are more than a decade old (and use data
that are decades older still).13
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No population-based study of marital status’ association with tumor stage at diagnosis
and survival has been conducted for the 3 cancers with established expert panel screening
recommendations for the average-risk U.S. adult population. Developing clear and up-to-date
information on these associations for each of the 3 cancers in population-based U.S. cohorts
could increase our understanding of factors that may be associated with the risk of adverse
prognoses and outcomes. These findings have the potential to improve the knowledge base
necessary to appropriately design, implement, and evaluate cancer prevention and control
efforts.
Research Aims
Research Aim #1: Assess differences in tumor stage at diagnosis and survival according to
marital status among a population-based cohort of males and females diagnosed with invasive
colorectal cancer between January 1st 2004 and December 31st 2006, while accounting for
relevant demographic and clinical characteristics.
Research Aim #2: Assess differences in tumor stage at diagnosis and survival according to
patient marital status among a population-based cohort of females diagnosed with invasive
breast cancer between January 1st 2004 and December 31st 2006, while accounting for relevant
demographic and clinical characteristics.
Research Aim #3: Assess differences in tumor stage at diagnosis and survival according to
patient marital status among a population-based cohort of females diagnosed with invasive
cervical cancer between January 1st 2004 and December 31st 2006, while accounting for
relevant demographic and clinical characteristics.
17

CHAPTER 2
LITERATURE REVIEW
Screening for Cancer
Effective cancer screening detects disease prior to clinical signs or symptoms.14 Two
necessary but not independently sufficient criteria for a screening modality to be considered
effective are that it must identify cancer before it’s detectable based on symptoms alone, and
that treatment undertaken as a result is likely to elicit an improved outcome relative to if the
cancer was discovered under normal circumstances.2 Cancers amenable to screening should
generally be diagnosed at an earlier stage and show an associated improvement in survival
prognosis.15 A disease-specific mortality reduction in a randomized, controlled prospective trial
is the strongest form of evidence supporting the candidacy of any proposed screening
modality.16 Additionally, declines in overall mortality and incidence, improvements in tumor
stage distribution, and reduced disease-related morbidity may also be considered when
weighing the benefits and harms of cancer screening. At the population level, appropriate
screening for colorectal, female breast, and cervical cancers reduces mortality from these
diseases.17
The American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF)
develop and regularly update cancer screening recommendations, and guidance from these
organizations is widely viewed as gold standards for cancer screening in the United States.
Since 1980 the ACS has updated and published evidence-based guidelines and
recommendations to foster informed decision-making on screening for cancers of the
18

colon/rectum, cervix, breast, prostate, endometrium, and most recently, lung. The ACS, in
collaboration with outside experts, monitors the scientific literature on a continuous basis, and
generally reviews and/or updates cancer screening guidance every 5 years, with summary
reviews published annually.12
The USPSTF, formed in 1984 by the Public Health Service and formally supported by the
Agency for Healthcare Research and Quality (AHRQ) since 1998, also publishes widely-adopted
evidence-based cancer screening guidance. Public Law 106-129 mandates that USPSTF provide
up-to-date scientific reviews to support evidence-based recommendations for preventive
services, including cancer screening.18 A screening method’s benefits must outweigh its harms,
among other criteria, in order for USPSTF to provide a recommendation. For the most part,
USPSTF’s recommendations closely resemble those made by ACS, although USPSTF guidance
tends to be slightly more conservative (i.e. restrictive) with respect to upper and lower limits
for age groups and recommended screening frequencies.
Based on the most recent ACS and USPSTF guidance, only 3 cancer sites--colon/rectum,
female breast, and uterine cervix--have unequivocal screening recommendations for averagerisk U.S. adults.12,18 In 2009, 351 706 new cases of these cancers (133 160 colorectal cancers ,
206 447 female breast cancers, and 12 099 cervical cancers) were diagnosed in the U.S. and
during 2008 there were 97 454 deaths due to these 3 diseases, a large proportion of which
could have been detected early or entirely prevented.4 It has been estimated that anywhere
from 3% to 35% of these premature cancer deaths could have been averted through proper use
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of screening tests.2 Table 1 presents the ACS’s 2013 estimations for new cases and deaths from
colorectal, female breast, and cervical cancers, as well as all cancers combined.19
Table 1: Estimated number of new invasive cases and cause-specific deaths, selected cancer
sites, United States, 2013

Source: Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for
clinicians. 2013;63(1):11-30.
Although screening for colorectal, female breast, and cervical cancer is clearly
recommended for average-risk adults, each of these screening methods has distinct age, sex
and frequency guidelines, which may differ based on which of the 2 organizations is making the
recommendations. In addition, there are certain risks and benefits associated with each
screening method that a patient should discuss with a clinical provider prior to having the
screening.12 Cancer screening should be viewed as a process rather than a series of isolated
procedures, with multiple steps and points of contact between healthcare organizations,
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clinicians, and patients.17 Any disruptions of this process could lead to a failure to detect cancer
and increase the likelihood of potentially avoidable morbidity and mortality. A recent literature
review of cancer screening found that half of all cervical cancers are diagnosed in women who
haven’t kept up-to-date with screening, and half of all older women diagnosed with advanced
breast cancer have never had a mammogram.17 In addition, poor adherence to screening
guidance likely contributes to the high levels of colorectal cancer mortality in populations with
low socioeconomic status.20
Screening Guidance for Colorectal Cancer
ACS and USPSTF colorectal cancer screening recommendations for average-risk adults
were each last updated in 2008. Both organizations recommend average-risk men and women
begin screening at age 50 years. USPSTF recommends ceasing screening at age 75 years, while
ACS does not define an upper age limit in its guidelines. There are several different colorectal
cancer screening modalities garnering recommendations, which can be divided into 2 general
categories: 1) tests that are capable of detecting cancer (includes fecal blood and DNA tests),
and 2) tests than are capable of detecting cancer and advanced adenomatous polyps (includes
endoscopic and radiological procedures).12 The distinction between these 2 categories is
provided to emphasize that prevention of colorectal cancer, and not just early detection, is
possible, although modalities in each group have unique strengths and weaknesses that should
be considered prior to choosing a screening method. ACS and USPSTF recommend an averagerisk adult undergo one of the following: colonoscopy every 10 years, fecal occult blood test
(FOBT) every year, or a flexible sigmoidoscopy every 5 years in conjunction with FOBT (every
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year per ACS guidance and every 3 years per USPSTF). ACS approves additional alternatives,
including double-contrast barium enema every 5 years or CT colonography (virtual
colonoscopy) every 5 years.12,21 USPSTF does not provide guidance on the use of barium enema
or CT colonography. In 2010, 17.2% of U.S. adults age 50 years and over reported having had a
blood stool test in the past 2 years, and 65.2% reported ever having a sigmoidoscopy or
colonoscopy.22 As of 2010, 58.3% of U.S. adults aged 50 to 75 years were currently meeting
USPSTF guidelines for FOBT, colonoscopy, or sigmoidoscopy (95% CI 57.0-59.6).23 In a British
population, van Jaarsveld and colleagues reported that married adults were 23% more likely
than non-married adults to report screening for colorectal cancer, and that inviting both
members of a married couple to screen together further increases uptake.24 Among 21 760
U.S. adults aged 50 to 85 years, Stimpson et al found that married individuals were 21% more
likely than the unmarried to report ever having colorectal endoscopy (sigmoidoscopy,
colonoscopy, or proctoscopy) and 49% more likely to report having an endoscopy during the 10
previous years.25
Screening Guidance for Female Breast Cancer
The ACS breast cancer screening recommendations for average-risk adult females were
last updated in 2003; USPSTF recommendations were last updated in 2009. USPSTF
recommends average-risk women start with screening mammography every 2 years beginning
at age 50 years, and continue through age 74 years. ACS recommends average-risk women
start with clinical breast examination (CBE) as part of periodic health exam (at least every 3
years) during their 20s and 30s. ACS guidance supports beginning annual mammography at age
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40 years, in conjunction with annual CBE, as part of a regular preventive health appointment.
ACS does not include an upper age limit for mammography in average-risk women.12,26 In 2010,
75.2% of American women age 40 years and over, and 77.9% of women age 50 years and over
reported having had a mammogram within the past 2 years.22 Coughlin et al examined data on
U.S. women age 40 years and over residing in metropolitan areas, and in unadjusted analysis
found that currently married or cohabitating women (80.4%) were more likely than
divorced/separated (75.5%), widowed (77.6%) and never married women (72.7%) to report
receiving a mammogram in the previous 2 years.27 The 95% confidence intervals for the
married/cohabitating compared to the marriage status groups showed statistical significance
(p < 0.05).
Screening Guidance for Cervical Cancer
The ACS cervical cancer screening recommendations for average-risk female adults were
last updated in 2002; USPSTF recommendations were last updated in 2012. USPSTF and ACS
both recommend women start screening for cervical cancer by age 21 years. USPSTF
recommends a Papanicolaou (Pap) test every 3 years for women age 21 years to 65 years, or a
Pap test/human papilloma virus (HPV) DNA test every 5 years for women age 30 years to 65
years. USPSTF doesn’t recommend screening beyond age 65 years for women who have stayed
current with appropriate screening, or for women who have had their cervix surgically
removed. ACS recommends screening women with conventional Pap tests every year, or every
2 years if using liquid-based Pap tests. Upon reaching 30 years of age, ACS recommends
women with 3 consecutive normal test results shift to a Pap test (either method) every 2 to 3
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years, or every 3 years if a Pap test is done in conjunction with a HPV DNA test. ACS suggests
halting screening in women over age 70 years who have had 3 consecutive normal Pap tests
and no abnormal results during the previous 10 years, or women who have had their cervix
completely removed.12,28 In 2010, 81.3% of U.S. women age 18 years and over reported having
had a Pap test in the past 3 years.22 Coughlin et al examined data on self-reported rates of Pap
testing among American women age 18 years and over living in metropolitan areas, and found
in multivariate analysis that divorced/separated and widowed women were approximately 30%
less likely to report a Pap test during the previous 3 years than those who were currently
married or cohabitating (OR=0.72, 95% CI 0.61-0.85 for divorced/separated and OR=0.69, 95%
CI 0.56-0.84 for widowed). Never-married women were much less likely than the currently
married or cohabitating to report a Pap test in the previous 3 years (OR=0.29, 95% CI 0.250.34).29 Hewitt et al examined a separate, nationally representative sample and came to a
similar conclusion. In adjusted analysis, they found that formerly married women between the
ages of 25 and 64 years were 25% less likely than currently married women to report a Pap test
during the previous 3 years, and never married women were half as likely to report screening.
The positive association between marriage and reported cervical cancer screening was even
more pronounced in women 65 years of age and older.30 Table 2 presents a summary of the
prevalence of adults in the U.S. who report being ‘up-to-date’ with recommended evidencebased clinical preventive cancer guidelines, per the recommendations of 2 leading
organizations.
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Table 2: Prevalence (%) of U.S. adults up-to-datea with recommended cancer screening per U.S.
Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) guidance, 2010,
with comparison to Healthy People 2020 goalsb

a
b

Up-to-date according to most recent published USPSTF and ACS guidance
Healthy People 2020 Goals screening prevalence goals refer to USPSTF recommendations

Although cancer develops within an individual person, its development is not
independent of external factors. Decades of scientific literature have suggested that both
patient-level and environmental factors can influence tumor characteristics and cancer
outcomes.31 Important factors directly affecting cancer survival, such as tumor stage, grade
and lymph node involvement, are fundamental to the disease itself; other factors associated
with survival may be external in nature.13 Research exploring the determinants of disparities in
stage at diagnosis and survival for various cancers has identified socioeconomic, cultural,
geographic, biomedical, and genetic factors as associated with variations in outcomes across
different population groups. Survival data broken down by racial and/or ethnic groups have
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played an essential role in helping clinicians and public health researchers identify at-risk
populations that may not be receiving adequate attention with respect to preventing and
treating cancers that can be detected early.15 It is also important to identify clinical and
socioeconomic characteristics that may contribute to disparate survival patterns across groups,
so as to improve the reach and cost-effectiveness of public health interventions.
Marriage in America
Marriage, and the responsibilities and expectations it entails, has different meanings in
different contexts. Family structure norms in the U.S. have undergone radical change in recent
decades. Economic and cultural forces have shifted societal standards for marriage, divorce,
cohabitation, childbirth, sexual behavior, and women’s roles in the home and workplace.32
Nearly all Americans still consider marriage and married life the ideal family structure, but the
institution is increasingly perceived as optional, and the notion of traditional marriage as a
dominant family and social structure has been on the decline for decades.32,33 Residents of the
U.S. have an increasingly broad definition of what constitutes a ‘family,’ and nearly all adults
cite their own family, in whatever form it takes, as the most important aspect of their lives. In
recent decades, there has been a sharp decline in the proportion of American adults who are
married, a trend shaped by opinions, attitudes, and behaviors that vary by age, race/ethnicity,
and class. Fifty-one percent of all adults living in the U.S. are currently married, the lowest
proportion in recorded domestic history. In 1960, 72% of U.S. adults were married.34 The
median age at first marriage in U.S. men (28.7 years) and women (26.5 years) has never been
higher than it is now.32,35 Researchers have observed declines in marriage rates among all age
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groups, but these are most pronounced in the younger population, with only 20% of adults age
18 to 29 years currently married compared to 59% in 1960.35 It is still impossible to know
whether contemporary young adults are simply delaying marriage or increasingly abandoning it
altogether, but contrary to widespread opinion, there is historical precedent for a reversal in
the slope of the marriage curve.
Current social commentators, many of whom grew up in 1950s post-war America, often
refer to that era as the normal “baseline” for the prevalence of marriage. However, average
age at first marriage (for men and women) was at an historic low in the 1950s and is an
anomaly compared to other time periods.32 This does not diminish the cultural significance of
the shifts observed in recent years. An increasingly egalitarian labor division has emerged
between men and women, conferring new societal and individual benefits, as well as
stressors.33 Young adults, both married and unmarried, now have expanded options for
housing, employment and education. The unmarried are currently much more likely than in the
past to live alone, which could signify a major shift in the composition of important social
support systems.32 Childless unmarried cohabitation, as well as single-parent childrearing, has
also become more prevalent, and decades of data suggest these trends are not related to
economic cycles.35 About half of U.S. adults cohabitate prior to nuptials, and increasingly, this
arrangement evolves into an permanent informal substitute for marriage.32 In a recent survey,
nearly 40% of Americans said marriage is becoming obsolete, but more than 60% of the
unmarried individuals in the same sample said they would like to marry someday.35 Along with
never-married adults, American communities have become increasingly supportive of single
parents and divorcees.33
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Although the broad societal trend has been towards a reduction in the overall
prevalence of marriage, some researchers have identified the emergence and growth of a socalled “marriage gap” in America.34 This “gap” exists between groups defined by race, income,
and education. As of 2010, 51% of all U.S adults were married, 14% were divorced or
separated, 6% were widowed, and the remaining 28% were never married. However, when
stratified by race, 55% of white, 48% of Hispanic, and only 31% of black adults were married.35
This gap is increasingly aligned with growing income disparities in the country.34 The recent
decline in the marriage rate has been much less precipitous among those with college
educations, with current college graduates 17% more likely to be married than those with a
high school education or less.35 These underlying trends have led some to label this
phenomenon as a “class-based” decline in marriage, highlighting systemic influences on the
role of marriage in our society.34 It has been hypothesized that additive effects of these
complex societal changes, compounded over time, may be contributing to expanding mortality
inequalities observed between married and unmarried populations.33 Recent opinion polls
asking about the acceptability of emerging nontraditional family structures found that the
young were more accepting than the old, political liberals were more accepting than
conservatives, and the secular were more accepting than the religious. Women have
essentially achieved parity with men with respect to overall workforce composition and
educational achievement, so it will be interesting to monitor how sex interacts with class-based
variables to influence marriage trends.34
Recent declines in marriage rates have been substantial, but Americans are still more
favorably inclined to marriage than residents of other developed countries.32 Although
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marriage rates are higher in the U.S. than in Europe and first world nations, the U.S also has
substantially higher divorce rates, although these have diminished over the last 20 years after
climbing consistently during the 1960s and 1970s.35 One-third of marriages starting in the
1950s ultimately ended in divorce, compared to almost half in recent years; the nation has
experienced something resembling a left-skewed bell curve over the past 60 years with respect
to divorce rates.32 Although the general public no longer sees marriage as the only path to a
happy family life, or as a sacrament that can only be broken in extremely rare circumstances,
the institution will no doubt continue to be promoted as a preferred lifestyle, both explicitly
and implicitly.33,34 Major religious institutions continue to promote marriage as the ideal family
structure, and the U.S. Federal government has formally endorsed marriage in legislation. The
Personal Responsibility and Work Opportunity Reconciliation Act of 1996, passed by the 104 th
Congress and signed by President Bill Clinton, clearly identified marriage as a foundation and
essential institution of a successful society.36
Marital Status, Cancer Stage at Diagnosis, and Survival
Many researchers have identified an association between marital status and overall
mortality. A recent international meta-analysis designed to estimate excess mortality in
unmarried elderly individuals showed an overall relative risk of 0.88 [95 % CI: 0.85-0.91] in the
married compared to the non-married, with minimal variation when results were stratified by
sex.37 The researchers found some evidence of publication bias, but ultimately their overall
estimate was consistent across several methodological approaches and sensitivity analyses. It
has been suggested that the protective association between marriage and mortality is likely a

29

result of enhanced support networks inherent to married and family life as well as the generally
high regard for married relationships in modern Western society.33 While this association has
been documented in the U.S. and Europe for both overall and disease-specific mortality in past
decades, the institution of marriage and its defining characteristics has undergone substantial
change in recent years, with modern society becoming increasingly accepting of never-married
adults, single parents, and divorcees.33,38-40 Americans across the socioeconomic spectrum still
view marriage as the ideal family structure, but increasingly this belief does not translate itself
into practice.32
In 1987, Goodwin et al were among the first to identify a favorable association between
marital status and likelihood of cancer diagnosis, treatment, and survival using populationbased data.41 It was already widely accepted that married individuals tended to live longer and
experience lower all-cause mortality, but Goodwin and colleagues demonstrated that
unmarried cancer patients were more likely to be diagnosed at an advanced tumor stage, more
likely to remain untreated, and prone to poorer overall survival. Their approach of controlling
for beneficial factors at the diagnostic, treatment, and response stages highlighted marriage’s
positive and independent influence at multiple stages of the disease process. The findings of
this study will be discussed further in subsequent sections.
Most research focused on specific cancer types has found a protective effect of
marriage, with cancer generally diagnosed at an earlier stage, and patients more likely to
receive recommended therapy, but population-based research has also demonstrated
conflicting findings about the association between marital status and stage, treatment, and/or

30

survival.38,40 In fact, 2 separate research groups analyzed recent population based cancer
registry data on bladder cancer patients, and arrived at contradictory conclusions.11,13 Both
studies examined outcomes in bladder cancer patients from the same nationally representative
cancer registry during nearly identical timeframes (those diagnosed between 1973 and 2000 in
the Gore study, 1973-2002 in the Nelles study), but Nelles considered all bladder cancer
patients (n=127 015) while Gore restricted analysis to those who’d had radical cystectomy for
transitional cell carcinoma of the bladder (n=7 262). Gore et al found that being married was
associated with improved survival from bladder carcinoma relative to unmarried patients,
independent of multiple factors known to influence survival, such as stage at diagnosis, gender,
age, and race/ethnicity. In contrast, Nelles et al analyzed population-based data from the same
registries and found that marriage did not seem to confer a definitive survival advantage for
bladder cancer patients after controlling for relevant confounders. The differences observed in
seemingly similar patient populations could be due in-part to potential lead time bias in Gore’s
subset population. There may be no true bladder cancer outcome benefit conferred by marital
status, but married patients may be more likely to undergo cystectomy early, creating the
illusion of longer survival when they could simply be experiencing better post-procedure
survival. Nelles et al stratified their population to try to detect this same effect among those
who’d had a cystectomy, but no such association was detected. Another factor potentially
influencing this observed difference for the same tumor type was that Gore and colleagues
considered overall survival, while Nelles et al calculated cancer-specific survival (death from any
cancer). In other words, the marriage-survival benefit observed by Gore may have been
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accounted for by deaths from ‘other causes’ in the non-married subsets of their bladder cancer
patient populations.
Marital Status and Colorectal Cancer
In 1987 Goodwin et al were among the first to study the association between marital
status and stage, treatment, and survival in patients diagnosed with cancer. They examined
tumor registry data representing all Hispanic and non-Hispanic white New Mexico adults (age
20+ years) diagnosed between 1969 and 1982. They separated cancers of the colon and rectum
for statistical analysis and found that unmarried patients had slightly higher likelihood of
nonlocal (regional or distant) disease at diagnosis for both cancers, but the odds ratio was not
statistically significant. After controlling for tumor stage at diagnosis, unmarried rectal (but not
colon) cancer patients were significantly less likely to receive definitive treatment. Upon
controlling for stage and treatment, unmarried colon cancer patients had a significantly
elevated risk of death (RR=1.27, 95% CI 1.11-1.45), but risk was not elevated in rectal cancer
patients (RR=0.97, 95% CI 0.84-1.28).41 In 1996 Johansen et al studied a cohort of Danish
patients diagnosed with colon or rectal cancer between 1968 and 1972, which allowed for
follow-up of more than 2 decades. Of the 7 302 individuals eligible for the study, married colon
cancer patients demonstrated significantly better 5-year survival than unmarried patients, even
after controlling for extent of disease (RR=0.85, 95% CI 0.78-0.93), but there was no survival
difference observed in rectal cancer patients in the same cohort.42 In 2010 Lai et al analyzed
the association between marital status and stage and diagnosis and survival in 72 214 U.S.
colon (rectum excluded) cancer patients (adults age 50 to 75 years) diagnosed between 1992
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and 2003. After adjusting for stage at diagnosis, they found that single patients had a 23%
higher risk of death compared to married patients, but this elevated risk was less pronounced
among widowed, separated, and divorced patients. Unmarried patients were also more likely
than married patients to be diagnosed with advanced stage colon cancer. The apparent
survival benefit in married individuals diminished once researchers controlled for stage at
diagnosis in survival models, suggesting that the protective benefit of marriage on cancer
survival may be explained in-part by its impact on stage at diagnosis.43 In 2011 Wang et al
examined this association in a U.S. population, again only in colon cancer patients. They
analyzed national data on 127 753 patients diagnosed with colon cancer between 1992 and
2006 and found that married patients were more likely to be diagnosed at an earlier stage
compared to single, separated, and divorced patients, and they were more likely to receive
definitive surgery than all unmarried (including widowed) individuals. Controlling for age, race,
tumor stage, and receipt of surgery, married colon cancer patients had lower risk of death than
single patients (hazard ratio (HR) in males, 0.86, 95% CI 0.82-0.90; in females, HR 0.87, 0.830.91).38
Marital Status and Female Breast Cancer
Goodwin and colleagues also examined the effect of marital status on female breast
cancer survival. They found that unmarried women had an increased likelihood of nonlocal
disease at the time of diagnosis (OR 1.24, 95% CI 1.09-1.42) and of failing to receive definitive
treatment (OR 1.34, 95% CI 1.02-1.76). However, after controlling for these 2 factors, there
was no association between marriage status and risk of death in female breast cancer patients
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(RR 1.03, 95% CI 0.92-1.16).41 In 2005, Osborne at al published nationally representative data
on U.S.-resident women diagnosed with breast cancer between 1991 and 1995. Of the 32 268
women age 65 years and older in the study population, unmarried women were more likely
than married to be diagnosed with late-stage (II-IV) cancer compared to early stage (I or in situ)
cancer (OR 1.17, 95% CI 1.12-1.23). Unmarried women with early stage disease were also less
likely than married women to receive definitive treatment. Upon controlling for stage at
diagnosis and treatment received, unmarried women were 25% more likely than married
women to die from breast cancer during the study period (95% CI 1.14-1.37). These data were
linked with Medicare records, which increased the amount of individual-level data available for
each patient. However, within this large cohort, patient socioeconomic status and
comorbidities ultimately had minimal impact on the independent association between marital
status and breast cancer survival.44
Marital Status and Cervical Cancer
Goodwin et al also examined data on New Mexico’s Hispanic and non-Hispanic white
women diagnosed with cervical cancer between 1969 and 1982, and found a marginally
significantly increased likelihood of nonlocal disease at time of diagnosis in the unmarried (OR
1.35, 95% CI 1.00-1.84). However, after controlling for stage at diagnosis, unmarried women
were much less likely than married to receive definitive treatment for cervical cancer (OR 3.41,
95% CI 1.77-6.55). Finally, when controlling for stage at diagnosis and receipt of treatment,
there was no statistically significant difference in risk of death between married and unmarried
women (RR 1.25, 95% 0.96-1.60).41 In 1990, Murphy et al published research examining
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survival among 1 728 women in southeastern England diagnosed with cervical cancer between
1972 and 1981. Although the researchers observed an apparent difference in crude survival by
marital status, this difference was accounted for after controlling for variations in age and stage
by marital status, at which point it became clear that there was no significant difference in
survival by marriage category.45 In 2010 Patel et al similarly found that among 7 997 women in
a nationally-representative U.S. sample of patients diagnosed with cervical cancer between
1992 and 1996, being married initially seemed to be associated with better 5-year survival
among the married compared to the unmarried. However, this advantage vanished once the
researchers corrected for tumor stage at diagnosis and receipt of definitive treatment,
suggesting that marriage’s role may be more pronounced in the portion of the cancer
continuum associated with early diagnosis and/or treatment decisions. In other words, most of
the observed survival benefit in this married population could be attributed to earlier stage at
diagnosis and/or higher likelihood of receiving radiation therapy.46
Mechanisms Potentially Explaining the Association
Several mechanisms have been suggested to explain the association between marriage
and improved cancer outcomes, but the selection effect and social causation are 2 theories
frequently mentioned in the literature.33,38,40 The selection effect, sometimes called health
selection or marriage selection, is based on the premise that healthy people may be more likely
than unhealthy people to get and stay married.33,38 In other words, good health may not be a
result of being married, but rather, marriage a result of good health.38 Kaplan et al suggested
that those who are seriously ill, or more likely to become seriously ill, may be perceived by
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others as less suitable marriage partners than those with a history of good health. Their
findings offer support for this idea, because within the population they studied, the
disadvantageous association between marriage status and mortality was stronger in those who
were never married than in those who had been married but had divorced or been widowed at
a later date.47
Social causation is the idea that social networks, or in this case marriage and the close
familial bonds that commonly come with it, provide important emotional support, cultivate
positively influential relationships, and encourage healthful behaviors.33,38 In as much as these
benefits are gained through transition into the married state, it has also been suggested that
loss of some of this support system, whether through divorce or widowing, could increase risk
of cancer-related morbidity and mortality.33 In a more tangible sense, encouragement from a
spouse may influence someone to elect to undergo screening, or pursue a more aggressive
treatment, which could advantageously influence stage at the time of diagnosis and survival
respectively.38 In those who’ve been diagnosed with a potentially treatable cancer, the
presence and support of a spouse may convince them that there is “more to live for.”
The Surveillance, Epidemiology, and End Results (SEER) Program
The Surveillance, Epidemiology, and End Results (SEER) program collects data from
tumor registries across the U.S. SEER is a standard of quality in the field of cancer outcomes
research and is the definitive source for population-based cancer incidence and survival data in
the United States.38,48 SEER disseminates population-based cancer data on patient
demographics, tumor site and morphology, extent of disease and treatment course, with
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follow-up to monitor vital status.49 The broad goals of the SEER Program are 4-fold: 1) report
regularly and accurately on U.S. cancer incidence, mortality, prevalence, and survival,
2) identify and monitor unusual cancer incidence trends in demographic and geographic
subpopulations, 3) report on trends in cancer stage at diagnosis and treatment/therapy
decisions, and 4) encourage research that promotes identification of factors to improve
effectiveness of comprehensive cancer control initiatives.49 The SEER Program is financially
supported by the National Cancer Institute (NCI) and the Centers for Disease Control and
Prevention (CDC). SEER’s Public Use Database is maintained by personnel from NCI’s Division of
Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics
Branch.40,48
In 1971 the National Cancer Act established the authority to collect, analyze, and share
national data relevant to cancer prevention, diagnosis, and treatment.49 In early 1973 the SEER
program started collecting data in 5 states and 2 metropolitan areas, and it has since expanded
to include tumor registries around the country. SEER now reports cancer-related data for
residents of Connecticut, Hawaii, Iowa, New Mexico, Utah, California, Georgia, Kentucky,
Louisiana, New Jersey, the Detroit and Seattle/Puget Sound metropolitan areas, and Alaska
Natives and American Indians in Arizona.48 Participating SEER regions and states were chosen
because they contained epidemiologically important and/or representative population groups
and possessed the capacity to maintain a population-based tumor registry system and regularly
report accurate data. Currently, SEER-participating registries collect and report cancer-related
data covering 28% of the U.S. population, with some oversampling for recognized racial/ethnic
minorities. Seventy-one percent of Hawaiian/Pacific islanders, 54% of Asian Americans, 43% of
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American Indians/Alaska natives, 41% of Hispanics, and 26% of African Americans residing in
the country are covered by SEER-participating registries. As of the most recently reported
diagnosis year, SEER registries have reported detailed information on more than 7 million
diagnosed cancer cases, with cases diagnosed since 2001 having tumor site and histology coded
according to International Classification of Diseases for Oncology, third edition (ICD-O-3)
standards.49,50
Collectively, the sub-populations comprising the SEER registries are nearly identical to
the broader U.S. population with respect to education and poverty levels, but the SEER
population has a higher proportion of foreign-born (17% vs. 11%) and urban (88% vs. 79%)
participants than the broader populace.48 State and regional registries participating in SEER
report all incident cancers diagnosed in their geographic areas each year.49 Participating
registries regularly conduct both passive and active cancer case follow-up; patient vital status is
verified through state and national death records, Health Care Financing Administration and
Social Security Administration files, voting, credit, and driver license records, and
hospital/physician records.15 The SEER Program complements these data with annual mortality
reports from the National Center for Health Statistics (NCHS). NCHS data include information
on deceased individuals in the geographic areas of interest, including age, sex, and
underlying/contributing causes of death.49 To assure accurate reporting of cancer incidence
and outcomes, SEER allows 22 months to elapse between the end of a diagnosis year and the
time of report to NCI. With each annual spring data release, existing case records from
previous years are updated if new patient information is available or entirely new diagnoses
from that time period (i.e. missed cases) are reported to registries. Historically, an initial annual
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SEER case count is about 2% below the total count that will eventually be registered for that
year.49
Cancer Staging in SEER
Extent of disease at the time of diagnosis is an important determinant of cancer
treatment course and is often a useful outcome predictor. Two prominent cancer staging
systems used in the U.S. include the American Joint Committee on Cancer’s (AJCC) Cancer
Staging Manual, commonly referred to as the TNM (tumor-node-metastasis) System, and the
Summary Staging System.51 The AJCC-maintained TNM System is predominantly used by
clinicians, with the ‘tumor’ component describing the invasiveness and size of the primary
tumor, the ‘node’ component describing the presence or absence of the cancer in nearby
lymph nodes, and the ‘metastasis’ component indicating whether or not there are distant
metastases and/or distant lymph node involvement.52
The SEER Program has developed a modified version of the Summary Staging System,
made possible through its consistent documentation of various characteristics relevant to
extent of disease. Data on extent of disease are more specific than stage alone, which allows a
cancer staged in the SEER system to remain comparable across multiple generations of AJCC
stage definitions.53 This characteristic of the SEER system is well suited to its primary use,
because SEER staging is used for population-based longitudinal research, while AJCC staging is
more commonly used in the clinical setting to inform decisions related to individual patient
prognosis. SEER staging can be used for all solid tumors but not for leukemias. It combines
information from medical records, clinical findings, and pathological reports.52 SEER summary
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staging consists of 5 categories: in situ, localized, regional, distant, and unstaged. A separate
localized/regional category applies only to prostate cancer cases and is not used in this study.54
Cancers coded in SEER as in situ are non-invasive tumors without malignant behavior that
haven’t extended through the basement membrane or beyond the epithelium. A localized
cancer is confined to the organ of origin, with rare exceptions, such as limited intraluminal
extension in colon cancer, assuming no lymph node involvement. Regional cancer has spread in
one of the following ways: 1) directly into surrounding tissue or organ(s), 2) into nearby lymph
nodes via the lymphatic system, or 3) via a combination of these 2 routes. Cancer classified as
distant has spread to parts of the body away from the primary tumor, via direct growth,
discontinuous metastasis to other organs, or to distant lymph nodes via the lymphatic system.54
Summary Statement
Much of the research described in preceding sections focused on the association
between marital status and stage, treatment, and outcomes for cancers originating in the
prostate, brain, bladder, kidney, and pancreas.11,13,31,39,40,55-57 While the findings are certainly
interesting and informative, those cancers do not have evidence-based early detection
methods likely to reduce mortality or morbidity. The focus of the current study is limited to the
3 cancer types for which there are screening methods proven to reduce mortality. Any findings
on protective associations for colon, cervical, and breast cancer have more potential for
translation to practices that could improve actual health outcomes. An enhanced
understanding of the effect of marital status on stage at diagnosis and ultimately cancer
survival could help clinicians and public health professionals identify subset(s) of the U.S.
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population at risk for adverse cancer-related outcomes, or who could stand to benefit from
targeted cancer prevention and control efforts.
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CHAPTER 3
METHODS
Based on a review of the literature, this appears to be the first population-based study
examining the association of marital status with tumor stage at diagnosis and survival for
cancers with definitive screening recommendations for the average-risk adult population. The
SEER Program, described previously, collects cancer patient data which is used for the analysis
in this study. Upon signing a data-use agreement, these data were made accessible through
the SEER Limited-Use database. The East Tennessee State University Office for the Protection
of Human Research Subjects has determined that this research proposal does not meet
established definitions for research involving human subjects and does not require Institutional
Review Board (IRB) approval. The University has issued a letter of exemption regarding human
subjects’ research.
The methods consist of the 3 following major components:
1. Descriptive statistics characterizing the 3 distinct patient populations
2: Bivariate and baseline category logit analysis of the association between marital
status and disease stage at the time of diagnosis; the latter will include steps to control
for confounding and assess effect modification
3: Development of Kaplan-Meier survival curves and Cox proportional hazards models
describing differences in patient survival across marriage categories while accounting
for potential confounders
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Overall Patient Population
Using the Case Listing Session function of the National Cancer Institute’s SEER*Stat
software version 8.0.1, all invasive primary site colon/rectum, female breast, and uterine cervix
cancers diagnosed between January 1st 2004 and December 31st 2006 in adults residing in a
SEER-participating state or region are identified and followed through November 2011. These
diagnosis dates are chosen to allow for up to 6 years and no less than 3 years of survival followup for all patients, depending on the date of diagnosis. Case data are downloaded using
SEER*Stat and the results matrix containing patient records is imported into SAS version 9.2
(Cary, North Carolina) for analysis. De-identified patient records include information on patient
demographics, tumor characteristics, and outcomes. The minimum age for patient inclusion in
the cohorts reflects the most liberal guidance for initiation of screening (specific to each tumor
site) within the average risk adult population according to evidence-based recommendations
made by ACS and USPSTF. Cancer anatomic site is categorized according to International
Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) standards.
Colorectal Cancer Cases
ICD-O-3 tumor site codes C18.0-C18.9, C19.9 and C20.9 are designated cancers of the
colon/rectum.54 These site codes include tumors originating in the cecum, appendix, ascending
colon, hepatic flexure, transverse colon, splenic flexure of the colon, descending colon, sigmoid
colon, rectosigmoid junction, overlapping lesions of the colon, and those originating in the
colon or rectum that are not otherwise specified (NOS). Lymphomas originating in lymphatic
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tissue of the colon/rectum are excluded. Minimum age for inclusion in the cohort is 50 years.
There is no upper age limit for inclusion.
Female Breast Cancer Cases
ICD-O-3 tumor site codes C50.0-C50.9 are designated cancers of the female breast.54
These include tumors originating in the nipple, central breast, upper-inner, lower-inner, upperouter and lower-outer quadrants, and axillary tail of the breast, as well as overlapping lesions of
the breast and breast tumors not otherwise specified (NOS). All male breast cancers and skin
cancers originating in breast tissue are excluded from analysis. Minimum age (at the time of
diagnosis) for inclusion in the cohort is 40 years. There is no upper age limit for inclusion.
Cervical Cancer Cases
ICD-O-3 tumor site codes C53.0-C53.9 are designated cancers of the uterine cervix.54
Only females are included in analysis. These site codes include tumors originating in the
endocervix, exocervix, cervix uteri, and overlapping lesions of the cervix uteri. Minimum age
for inclusion in the cohort is 20 years. There is no upper age limit for inclusion.
Independent Variable
The independent variable is patient marital status at the time of diagnosis report to the
registry for the referent tumor. During the time frame of this study, there were 6 possible
categories in the SEER database for marital status: 1) married (including common law marriage),
2) single (never married), 3) separated, 4) divorced, 5) widowed, and 6) unknown.58 If a patient
declares him/herself married at the time of diagnosis, then it is reported as such (SEER defines
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marriage as a self-reported state). Separated and divorced are combined into one category
(divorced/separated) per research precedent, but other categories remain as defined by the
SEER program.11 Completeness of the marital status variable within SEER was 95% for patients
diagnosed from 1973-2007, with minimal variation in completeness by patient vital status.
Stage at Diagnosis
SEER Historic Stage A, a unique summary stage for tumors, is used to categorize cancer
stage at the time of diagnosis.54 Historic Stage A is created by collapsing comprehensive extent
of disease information collected by the SEER Program, and stage categories relevant to this
analysis include in situ, localized, regional, distant, and unstaged. Patients with tumors lacking
malignant behavior and those with tumors left unstaged are excluded from analysis.
Covariates
Other patient variables included in analysis are sex (for colorectal cancer only), race,
age, education, household income, and residential status. Modeled small area estimates of the
percentage of the female population with a mammography in the past 2 years and a Pap test
within the past 3 years are also available for breast and cervical cancer patients.
The sex variable categorizes the patient as either male or female at the time of diagnosis. For
publication purposes, the SEER Program collapses specific racial categories into white, black,
other (defined as American Indian/Alaska Native, Asian/Pacific Islander), unspecified, and
unknown. The age variable refers to the patient’s age in years at the time of tumor diagnosis.
The age variable is treated as a categorical variable and stratified according to research
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precedent and the recommended age range for each screening modality. For colorectal cancer
patients, age is categorized into 4 groups: 50-59 years, 60-69 years, 70-79 years, and 80 years of
age or greater. Female breast cancer patients are categorized in 5 age groups: 40-49 years, 5059 years, 60-69 years, 70-79 years, and 80 years of age or greater. Cervical cancer patients are
also divided into 5 age groups: less than 40 years, 40-49 years, 50-59 years, 60-69 years, and 70
years of age or greater. Residential status, income, and education are county-level attributes
using U.S. Census Bureau data.59 For the educational attainment variable, percentage of county
residents age 25 years and older with less than a high school education was linked to the
individual patient record. For the income level variable, median household income in the
county of residence was linked with the patient record. For residential status, the Rural-Urban
Continuum Code, developed by the U.S. Department of Agriculture, is used to characterize the
population size of the patient’s county of residence. Rural-Urban Continuum Codes
characterize metropolitan counties by the population size of the metropolitan area(s) within
their borders, and nonmetropolitan counties by the degree of urbanization within and adjacent
to metropolitan area(s) in neighboring counties. Codes developed in 2003 are used for analysis.
Rural-Urban Continuum Codes have 9 categories ranging from counties in metropolitan areas
with greater than 1 million residents to completely rural counties with less than 2 500 residents
not adjacent to a metropolitan area.59 Categories 1 through 3 are metropolitan with
populations of at least 250 000 persons, and categories 4 through 9 are nonmetropolitan,
ranging from small urban areas adjacent to metropolitan areas down to sparsely populated
rural and frontier areas not adjacent to metropolitan centers. Due to limitations of Rural-Urban
Continuum Code availability for the state of Alaska, all patients from this SEER registry are
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classified as nonmetropolitan for analysis. The modeled small area estimates for breast and
cervical cancer screening are developed by the National Cancer Institute using Behavioral Risk
Factor Surveillance System (BRFSS) and National Health Interview Survey (NHIS) data. These
estimates are ecological and available at the health service area (HSA) level.
Descriptive Statistics
Descriptive statistics and clinical characteristics of the patient population for male and
female colorectal, female breast, and cervical cancer patients are summarized in table format,
and chi-square tests are used to assess unadjusted associations between categorical variables.
Ecological county-level attributes are not characterized descriptively because they don’t
represent individual-level characteristics. Patients with missing information for marital status,
tumor stage, age and/or race are excluded.38
Baseline Category Logit Models
Following the descriptive analysis, the next step is determination of the likelihood of
advanced stage cancer (regional or distant) at the time of diagnosis. Bivariate associations
between potential covariates and the outcome variable stage at diagnosis are calculated, with
those covariates showing independent statistically significant associations (at p=0.05) with the
outcome eligible for inclusion in the multiple regression models. Baseline category logit models
are then fit for each of the 3 patient cohorts. This is an unconditional, nominal logistic multiple
regression model with the dependent variable stage. The 2 non-reference categories (regional
and distant disease) are contrasted with the baseline referent (localized disease). The Logistic
Procedure in SAS software fits these models using a maximum likelihood estimation when the
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generalized logit option (LINK=GLOGIT) is specified in the MODEL statement. Analysis includes
assessment for effect modification between marital status and relevant covariates such as sex
and race.
Patient Survival Time and Follow-up
Survival time can’t be analyzed as a simple continuous outcome variable because time
to event is not known for all patients. Because patients are diagnosed with cancer at different
points in the study period, follow-up time differs across each of the 3 cohorts. By taking followup time into account, the power and precision of results are improved. Survival time is
measured in months from the time of cancer diagnosis with adjustment for censoring from any
of the following conditions: 1) patient is lost to follow-up; 2) patient dies from any non-cancer
cause; 3) patient survives to the end of the follow-up portion of the study period. Patients are
followed for up to 6 years, and for a minimum of 3 years, to allow for sufficient data for survival
analyses while still assuring a contemporary patient population. It is necessary to restrict
analysis to patients diagnosed after January 1st, 2004, because before that time the SEER
Program derived summary tumor stages (including SEER Historic Stage A) using outdated extent
of disease information that have limited comparability across time. The 2011 SEER Program
data submission, made public in April 2012, contained a patient follow-up cutoff date of
December 31st, 2009.54
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Survival Analysis
Separate survival analyses are conducted for each of the 3 cancer patient cohorts. Each
survival analysis specifies death resulting from any cancer as the outcome of interest (patient
failure). This outcome is used because death from any cancer may not be independent of the
primary tumor in a population already diagnosed with invasive cancer, especially when
considering that post-diagnosis follow-up consists of no more than 6 years for any given
patient.13 Population-based research evaluating agreement between initial cancer diagnosis
and coded cause of death found that approximately 85% of deaths within the first decade of
follow-up were attributed to the tumor-specific diagnosis listed in SEER, but an additional 8% of
deaths were attributed to another type of cancer.60 A portion of this 8% could be attributed to
distant metastases, or could be due to physicians reporting nonspecific tumor sites on death
certificates. The reliability of relative (overall) survival as an outcome measure for cancer
patients is questionable if life tables don’t accurately portray true mortality in all sub-groups of
the population. Reliability of a standard life table could vary by group because of differences in
the distribution of “other causes” of mortality due to socioeconomic, lifestyle, or genetic risk
factors. The SEER Program oversamples certain American minority populations (e.g. Alaska
Natives, Cherokee Nation) to allow for improved cancer incidence and outcome data in these
relatively small populations. The NCHS doesn’t publish life tables for Asian Americans or
American Indians, and racial/ethnic misclassification on death certificates has been found to be
high within minority populations.53 In cancer research, it is common to focus on overall survival
rather than cancer-specific survival. This approach may be most useful when evaluating
effectiveness of cancer-directed therapies that place patients at risk for non-cancerous adverse
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events. However, when evaluating cancer outcomes in populations with older age
distributions, as is the case with breast, cervical, and colorectal cancer patients, it is
advantageous to calculate cancer-specific survival because older individuals are also at
increased risk of death from unrelated causes. Minority (blacks and non-white Hispanics)
cancer patients are also more likely than white cancer patients to die of diseases or conditions
other than cancer.60
SEER*Stat software allows users to request a cause of death recode. Deaths within the
3 patient cohorts are stratified by “cancer causes of death” and “non-cancer causes of death”
to allow development of a cancer-specific cause of death category in survival analyses. Thus, at
the time of failure or censoring, patients are classified as either alive, dead from any malignant
cancer, or dead from all other causes combined (e.g. diseases of the heart, septicemia, suicide,
etc.), including in situ, benign, or unknown behavior neoplasms.
An important early step during the analysis of survival data is the estimation of the
distribution of patient failure times. The LIFETEST procedure in the SAS software package can
be used to compute nonparametric estimates of the cancer-specific survival function using the
product-limit method. Kaplan-Meier product limit estimators for survival functions by each
marital status category are assessed, with differences tested using the log-rank test. Death
from any malignant cancer (referred to as cancer-specific death) is considered the event of
interest, while non-cancer deaths and those who survived through follow-up are censored. 36month cancer-specific survival probabilities are calculated and compared across each marital
status category.
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The PHREG procedure in SAS software allows users to perform multiple regression
analysis of patient survival data based on the semiparametric Cox proportional hazards model.
Cox proportional hazards analysis can help quantify the effect of predictor variables on hazard
rates within a population. In the current study the model is used to quantify the risk of death
from any cancer during the follow-up period and to estimate the independent association
between marital status and cancer death for colorectal, female breast, and cervical cancer
patients. A backward elimination process with p=0.20 set as cut-off level for covariates is used
to determine those that may have a meaningful effect on cancer-specific survival among
colorectal, female breast, and cervical cancer patients. Tests for violations of the proportional
hazards assumption are conducted through assessment of Shoenfeld residuals.
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CHAPTER 4
RESULTS
Patient Population Characteristics
Of the 103 144 colorectal cancer patient records retrieved from the SEER database,
92 705 had complete demographic and clinical information. Of the 151 155 female breast
cancer patients, 141 561 complete records were available; of the 10 267 cervical cancer
patients, 9 239 complete records were available. Descriptive tables in this section characterize
each of the 3 patient populations, stratified by marital status (married, divorced/separated,
widowed and single).
Colorectal Cancer Patient Characteristics
The 92 705 colorectal cancer patients eligible for analysis represent 89.9% of the total
original cohort downloaded from the 18 participating SEER cancer registries. Those excluded
comprise 529 patients listed as unknown race, 6 115 with unknown stage at diagnosis and
4 754 with unknown marital status. The total number of missing values for these variables
amounts to slightly more than the total number of patients excluded because a small number
of observations (individuals) had missing values for more than one measure. Colorectal cancer
patients with unknown marital status were not substantially different from those with known
marital status with regards to several important variables. Those with unknown marital status
were 1.5% more likely to be younger than age 70 years, 2.9% more likely to be female, 0.8%
more likely to be black, and 3.2% less likely to be diagnosed with distant stage disease.
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Fifty-two thousand six hundred thirty-one (56.8%) of the patients eligible for analysis were
married at the time of diagnosis, 8 703 (9.4%) were divorced or separated, 21 234 (22.9%) were
widowed and 10 137 (10.9%) were single (Table 3).
Table 3: Demographic and clinical characteristics of colorectal cancer patients, SEER cancer
registries, 2004-2006 diagnoses, n=92 705

Statistically significant (p<0.0001) differences existed between the 4 marital status categories as
defined by patient age, sex, race, residential status, and disease stage. Single colorectal cancer
53

patients were more likely to be in the youngest (50-59 years) age group, while widowed
patients were far more likely than others to be 80 years of age or older; divorced/separated
patients were least likely to be 80 years of age or older at diagnosis. Widowed patients were
more likely than others to be female, while married patients were predominantly male. The
divorced/separated and single populations had approximately equal distributions of males and
females. A majority of these colorectal cancer patients was white (82.2%), and whites were
more likely than other groups to be widowed. Black patients were approximately twice as likely
as whites to be divorced/separated or single. Proportionally, patients classified as ‘other’ race
were more likely to be married than any other marital status category. At least 85% of
colorectal cancer patients in each of the 4 marital status categories lived in metropolitan areas,
with single patients more likely to be metropolitan and widowed patients most likely to be
nonmetropolitan. Married patients were more likely than others to be diagnosed with localized
disease; divorced/separated and single patients were less likely than those who were married
or widowed to have localized disease at diagnosis and more likely to have distant stage disease.
Married patients were least likely among the 4 categories to have distant stage disease at the
time of diagnosis.
Female Breast Cancer Patient Characteristics
The 141 561 female breast cancer patients eligible for analysis comprise 93.7% of the
total cohort downloaded from the SEER registries. Those excluded consist of 706 patients listed
as unknown race, 3 500 with unknown disease stage at diagnosis and 6 298 with unknown
marital status. There were no apparent major differences between those included in and
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excluded from analysis with regards to several important covariates. Female breast cancer
patients with unknown marital status were 3.6% less likely to be younger than age 60 years;
there was no difference in the racial composition of the groups. Those with unknown marital
status were 1.3% more likely to be diagnosed with distant stage disease than those who had
known marital status recorded in the SEER registries.
Seventy-nine thousand seven hundred twenty-two (56.3%) of the patients included in
analysis were married at the time of diagnosis, 16 969 (12.0%) were divorced/separated, 27 118
(19.2%) were widowed and 17 752 (12.5%) were single (Table 4). Statistically significant
(p<0.0001) differences existed between the 4 marital status categories by patient age, race,
residential status, and disease stage. Proportionally, single female breast cancer patients were
more likely than others to be in the youngest (40-49 years) age category; widowed patients
were more likely to be in the oldest (80+ years) age group. Married and divorced/separated
patients were more likely than those in other marital status groups to be between 50 and 59
years of age at diagnosis. A clear majority of patients in all 4 marital categories was white, with
those of ‘other’ race most likely to be married and those who were black most likely to be
divorced/separated or single. Black patients were more likely to be single (26.3%) than those in
the other 2 marital status groups, and patients classified as ‘other’ race were more likely to be
married (65.3%). Breast cancer patients in all marital categories predominantly lived in areas
classified as metropolitan, with single patients most likely to reside in metropolitan areas, and
widowed patients most likely to live in nonmetropolitan areas.
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Table 4: Demographic and clinical characteristics of female breast cancer patients, SEER cancer
registries, 2004-2006 diagnoses, n=141 561

Married and widowed patients were more likely than others to have localized breast cancer at
the time of diagnosis; single patients were least likely to have localized disease. Single females
were also more likely than others to have regional or distant stage breast cancer at the time of
diagnosis; married patients were least likely to be diagnosed with distant stage disease.
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Cervical Cancer Patient Characteristics
The 9 239 cervical cancer patients eligible for analysis comprise 90% of the original
cohort downloaded from the SEER registries. Those excluded were 82 patients listed as
unknown race, 523 with unknown stage at diagnosis, and 567 with unknown marital status.
Cervical cancer patients with unknown marital status did not differ markedly from those with
known marital status with respect to age (54.62% of those with known marriage and 54.63% of
those with unknown marriage younger than age 50 years). Patients with unknown marital
status were 0.6% less likely to be black, as well as 0.6% less likely to have distant stage cervical
cancer at the time of diagnosis.
Four thousand three hundred seventeen (46.7%) of these patients were married at the
time of diagnosis, 1 343 (14.5%) were separated/divorced, 1 063 (11.5%) were widowed and
2 516 (27.2%) were single (Table 5). Statistically significant (p<0.0001) differences existed
between the 4 marital status categories as defined by patient age, race, residential status, and
disease stage. Proportionally, single cervical cancer patients were more likely than those in
other marital status groups to be younger than 40 years of age. Widowed patients were the
most likely of the 4 marital status groups to be age 70 years or older at the time of diagnosis.
Married patients were more likely than others to be between 40 and 49 years of age at
diagnosis. As with the colorectal and female breast cancer cohorts, a majority of cervical
cancer patients in this population was white. Black patients were more likely to be single
(46.0%), while white patients were more likely than others to be divorced/separated (15.6%).
Those patients classified as ‘other’ race (50.1%) were more likely than others to be married.
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Table 5: Demographic and clinical characteristics of cervical cancer patients, SEER cancer
registries, 2004-2006 diagnoses, n=9 239

Most cervical cancer patients lived in metropolitan areas. Proportionally, single patients were
more likely to live in metropolitan areas, and widowed were more likely to live in
nonmetropolitan areas. Married patients were more likely than others to have localized
disease at diagnosis and were least likely to have distant stage disease. Conversely, widowed
patients were least likely to have localized disease at diagnosis and more likely than those in
the other 3 marital status groups to be diagnosed with regional or distant disease.
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Marital Status and Advanced Tumor Stage at Diagnosis
The proportional odds assumption was not met with these data, so the dependent
variable tumor stage at diagnosis could not be treated as ordinal. Table 6 presents results of
the baseline category logit model assessing marital status and other factors’ relationships with
stage of colorectal cancer at the time of diagnosis. The 2 results columns (labeled ‘Regional’
and ‘Distant’) contain odds ratios comparing patients in categories of the primary predictor and
each covariate to a category-specific baseline referent with respect to their likelihood of being
diagnosed with the later stages of either regional or distant as compared to the basline
outcome of localized cancer. Ecological variables serving as proxies for educational level and
income did not meaningfully improve the model, and were not included as covariates in the
final model.
Patients in each of the 3 ‘non-married’ categories (divorced/separated, widowed, single)
were significantly more likely to have regional (vs. localized) and distant (vs. localized) stage
colorectal cancer at the time of diagnosis compared to married patients (p-value range:
<0.0001-0.0007). Divorced/separated patients had the highest likelihood of later stage disease
relative to married patients for both stage comparisons (OR=1.11, 95% CI 1.05-1.17 for regional
vs. localized and OR=1.36, 95% CI 1.28-1.44 for distant vs. localized). Females were slightly
more likely than males to have regional stage disease at diagnosis (OR=1.06, 95% CI 1.03-1.09),
but there was no discernible female vs. male difference for the distant vs. localized stage
disease comparison (p=0.0626).
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Table 6: Baseline category logit analysis of marital status and other factors predicting colorectal
cancer stage at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=92 705

There was no apparent trend in effect size change with advancing patient age (ORs 0.99, 0.94
and 0.95 for 60-69, 70-79, and 80 years of age and older, respectively) for the regional vs.
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localized comparison, while for the distant vs. localized comparison progressively higher age
groups seemed to enjoy modestly larger protective effects (OR=0.94, 95% CI 0.89-0.99,
OR=0.79, 95% CI 0.75-0.84, and OR=0.78, 95 % CI 0.73-0.82 for 60-69, 70-79, and 80 years of
age and older, respectively). There was no significant difference between black and white
patients for the regional vs. localized comparison (p=0.6007) or between those classified as
‘other’ race and whites for the distant vs. localized comparison (p=0.9477). Those of ‘other’
race were slightly more likely than whites to have regional vs. localized disease (OR=1.09, 95%
CI 1.03-1.15), and blacks were 25% more likely than whites to have distant vs. localized stage
colorectal cancer at diagnosis (OR=1.25, 95% CI 1.18-1.32). Residing in a nonmetropolitan area
seemed to be marginally protective, but the odds ratios for these measures were close to null
for both regional vs. localized and distant vs. localized comparisons (0.93, 95% CI 0.89-0.97 and
OR=0.94, 95% CI 0.90-0.99 respectively). The variable for patient sex appeared to modify the
relationship between marital status and stage (p=0.0003), and the data were subsequently
stratified (See Appendix A). After stratifying by sex, divorced/separated, widowed, and single
males were more likely to be diagnosed with distant vs. localized disease than females, with the
disparity in effect sizes most pronounced among the divorced/separated (OR 1.49, 95% CI 1.371.62 in males compared to OR 1.22, 95% CI 1.12-1.33 in females) and single patients (OR 1.46,
95% CI 1.36-1.58 in males compare to OR 1.17, 95% CI 1.07-1.27 in females). It would appear
that among colorectal cancer patients, the protective association between marriage and
disease stage at diagnosis is stronger in men than women.
Table 7 presents results of the baseline category logit model characterizing the
association of marital status and other factors with later stage breast cancer at diagnosis.
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Table 7: Baseline category logit analysis of marital status and other factors predicting female
breast cancer statge at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=141 561

Ecological variables for education, income, and screening mammography did not
meaningfully improve the model and were excluded from the final version. Residential status
was also excluded as a covariate during model development due in part to a low Wald χ 2 value
noted during analysis of effects. The variable exceeded the 0.2 significance level specified for
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removal of potential covariates during backward model selection. Marital status, age, and race
were included as predictor variables in the final model.
Women in the divorced/separated, widowed, and single categories were significantly
more likely than those in the married category to have regional vs. localized breast cancer at
the time of diagnosis, with the effect size more considerable across these same categories for
the distant vs. localized disease comparison. Single women were most likely to be diagnosed
with tumors at the lastest stage; they had a 77% higher likelihood of distant vs. localized
disease than those who were married (OR=1.77, 95% CI 1.66-1.99). Advanced age had a
progressively larger protective effect for the regional vs. localized disease comparison, while
the 4 older (compared to the referrent) age groups in the distant vs. localized comparison
demonstrated no uniform trend, with 2 of the outcome measures (for ages 60-69 and 70-79
years) failing to reach statistical significance. Black patients had higher likelihood than whites
of regional vs. localized (OR=1.33, 95% CI 1.28-1.38) and distant vs. localized disease (OR=1.83,
1.72-1.95) at diagnosis, while those classified as ‘other’ race were not significantly different
from whites at either level of comparison. An interaction term for race by marital status was
marginally significant (p=0.0430), and data were stratified by race (See Appendix B). Once
stratified by race, the only substantial departures from effect sizes observed in the full model
were among divorced/separated and single women classified as ‘other’ race. These women
had more than twice the likelihood of distant vs. localized disease at diagnosis compared to
married peers (OR=2.05, 95% CI 1.54-2.73 and OR=2.29, 95% CI 1.81-2.91 for
divorced/separated and single, respectively). Smaller sample sizes and less precise estimates
within this stratification scheme, evidenced by wider confidence intervals, could play a role in
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these observed differences, although a majority of the effect size estimates for white and
‘other’ race patients are statistically significant.
Table 8 presents results of the baseline category logit model describing the association
of marital status and age with later stage cervical cancer at the time of diagnosis.
Table 8: Baseline category logit analysis of marital status and other factors predicting cervical
cancer stage at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=9 239
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Ecological variables for education, income, and Pap test prevalence, as well as individual-level
variables for race and residential status did not meaningfully improve the model and were
excluded either prior to full model development or during a backward elimination process.
Women in each of the 3 non-married categories were more likely than those who were married
to have regional vs. localized cervical cancer at diagnosis, with divorced/separated women
having the greatest increased likelihood (OR=1.49, 95% CI 1.31-1.71). The same is true for the
distant vs. localized comparison, except that single women had the highest likelihood of distant
disease relative to the married (OR=1.68, 95% CI 1.42-1.98). While controlling for patient
marital status, there was a distinct age gradient, with elevated likelihoods of later stage disease
relative to the youngest age group for both baseline stage comparisons. The adverse
association with advanced age was more pronounced within each categorical stratum in the
distant vs. localized compared to the regional vs. localized column. Those who were 70 years of
age or older had more than 4 times (OR=4.19, 95% CI 3.51-5.00) higher likelihood of being
diagnosed with regional vs. localized cervical cancer than those younger than age 40 years,
while the oldest patients were nearly 6 times more likely than the youngest (OR=5.78, 95% CI
4.39-7.61) to have distant vs. localized disease at the time of diagnosis.
Marital Status and Cancer-specific Survival
Colorectal Cancer and Survival
Figure 5 shows cancer-specific survival probability curves comparing colorectal cancer
patient survival by marital status category. Unadjusted Kaplan-Meier survival analysis
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demonstrated that throughout follow-up, married patients had better cancer-specific survival
than those who were divorced/separated, single, and widowed.

Figure 5: Kaplan-Meier plot, colorectal cancer patient survival, in months, stratified by marital
status, SEER cancer registries, 2004-2006 diagnoses
The log-rank test for equality across marital status strata was statistically significant (p<0.0001).
Of the 33 547 patients who died of any cancer during follow-up, 16 557 (49.4%) were married,
3 488 (10.4%) were divorced/separated, 3 986 (11.9%) were single, and 9 516 (28.4%) were
widowed. 64 842 patients were right censored (survived or died of a non-cancer cause), of
whom 38 285 (59.0%) were married, 5 809 (9.0%) were divorced/separated, 6 809 (10.5%) were
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single, and 13 939 (21.5%) were widowed. At 36 months, the longest uniform follow-up time
for all individuals, cancer-specific survival was 73.3% for married, 65.4% for divorced/separated,
65.2% for single, and 59.7% for widowed patients.
Among patients diagnosed with invasive colorectal cancer, being married at the time of
diagnosis was associated with superior cancer-specific survival during the follow-up period,
independent of sex, age, race, and disease stage (Table 9). Ecological variables for education
level and household income, as well as a variable characterizing patient residential
(metropolitan vs. nonmetropolitan) status did not meaningfully improve the multiple regression
model, and were excluded from the final version. Divorced/separated and single patients had
approximately 30% higher risk of death during follow-up (Hazard Ratio=1.29, 95% CI 1.24-1.34
and HR=1.30, 95% CI 1.25-1.35, respectively) than those who were married at the time of
diagnosis; widowed patients had 24% higher risk of death during follow-up than married
patients (HR=1.24, 95% CI 1.20-1.28). Controlling for other relevant factors, females had a
lower risk of death during follow-up (HR=0.88, 95% CI 0.85-0.90), and advancing age was
consistently associated with increased risk of cancer-specific death, with a nearly 3-fold
increase in risk among those who were 80 years of age or older compared to those in the
youngest age group (HR=2.70, 95% CI 2.60-2.80). Black colorectal cancer patients had a 20%
higher risk of death than whites at any point during follow-up, while being classified as ‘other’
race was associated with slightly better survival. Having regional stage colorectal cancer at
diagnosis was associated with more than 2-fold higher risk compared to those with localized
disease (HR=2.31, 95% CI 2.24-2.39), while those with distant stage disease were nearly 13.5
times more likely to die of any cancer during the follow-up period (HR=13.43, 95% CI 13.0167

13.86). Patient sex modified the association between marital status and cancer-specific
survival, and data were stratified by sex to assess the effect this interaction may have on hazard
ratios in the full model (See Appendix C).
Table 9: Multivariate Cox proportional hazards model for marital status and other variables
predicting death from any cancer among colorectal cancer patients, SEER cancer registries,
2004-2006 diagnoses
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Although a term included in the model to assess for interaction between patient sex and
marital status was statistically significant (p=0.0045), following stratification, the changes in
hazard ratios across marital status categories were relatively minor. However, it appears that
being married was more protective among male colorectal cancer patients than among
females, as hazard ratios for divorced/separated, widowed, and single patient groups were 1.34
(95% CI 1.27-1.42), 1.26 (95% CI 1.20-1.33), and 1.37 (95% CI 1.31-1.44) respectively, all
modestly higher than those observed among female counterparts. This aside, it’s clear that
while controlling for relevant factors available in the SEER registry database, colorectal cancer
patients in each of the 3 ‘non-married’ categories were at significantly higher risk of cancerspecific death during the years immediately following their diagnoses.
Breast Cancer and Survival
Unadjusted Kaplan-Meier survival curves showed married breast cancer patients with
the highest survival probability, divorced/separated and single with nearly identical curves and
widowed patients with the lowest cancer-specific survival probability (Figure 6). The log-rank
test for equality across strata was statistically significant (p<0.0001). Of the 18 320 female
breast cancer patients who died of any cancer during follow-up, 7 651 (41.8%) were married,
2 486 (13.6%) were separated/divorced, 2 756 (15.0%) were single, and 5 427 (29.6%) were
widowed. Of the 126 537 patients who were censored, 73 171 (57.8%) were married, 14 876
(11.8%) were separated/divorced, 15 466 (12.2%) were single, and 23 024 (18.2%) were
widowed. After 36 months of follow-up, cancer-specific survival was 93.1% for married, 88.8%
for divorced/separated, 87.7% for single, and 83.6% for widowed patients.

69

Figure 6: Kaplan-Meier plot, female breast cancer patient survival, in months, stratified by
marital status, SEER cancer registries, 2004-2006 diagnoses
Married females diagnosed with invasive breast cancer had lower risk of death than
those in all 3 non-married categories, independent of age, race, and tumor stage at diagnosis
(Table 10). Ecological variables serving as proxies for patient household income, education and
mammography screening prevalence, as well as an individual-level variable describing
residential status, didn’t improve the model and were excluded from the final version.
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Table 10: Multivariate Cox proportional hazards model for marital status and other variables
predicting death from any cancer among female breast cancer patients, SEER cancer registries,
2004-2006 diagnoses

The elevated risk of cancer-specific death was nearly uniform across the divorced/separated,
widowed, and single groups with hazard ratios of 1.29 (95% CI 1.23-1.36), 1.31 (95% CI 1.261.37), and 1.33 (95% CI 1.27-1.39) respectively. Risk of cancer-specific death was progressively
higher with increasing age, with those patients age 80 years and older having nearly 3 times the
risk of those between the ages of 40 and 49 years (HR=2.94, 95% CI 2.77-3.12). As was the case
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in colorectal cancer patients, but within this cohort to a greater extent, black female breast
cancer patients had higher risk of cancer-specific death (HR=1.66, 95% CI 1.59-1.73 compared
to whites), while those classified as ‘other’ race enjoyed a small protective association
(HR=0.88, 95% CI 0.82-0.95). Once again, disease stage was inversely proportional to cancerspecific survival during follow-up, with nearly 3-fold and more than 20-fold higher risk of death
from any cancer among those with regional and distant stage breast cancer respectively
(HR=2.90, 95% CI 2.80-3.02, HR=20.69, 95% CI 19.90-21.50). Upon inclusion of a model term
assessing interaction, it appeared that the variable race modified the association between
patient marital status and cancer-specific survival during follow-up (p=0.0002). Data were
stratified by race and the new models were interpreted (See Appendix D). Effect sizes across
each of the 3 non-married categories remained essentially unchanged among whites (HR=1.30,
95% CI 1.23-1.37, HR=1.31, 95% CI 1.25-1.37, and HR=1.27, 95% CI 1.20-1.34 for
divorced/separated, widowed, and single breast cancer patients respectively). Among the black
female breast cancer patient population, the protective effect was slightly lower among the
divorced/separated and widowed patients relative to the married (HR=1.20, 95% CI 1.07-1.35
and HR=1.28, 95% CI 1.14-1.45 respectively), while risk of death among single patients was
modestly higher relative to the entire population (HR=1.36, 95% CI 1.23-1.50 in blacks
compared to HR=1.33, 1.27-1.39 in the full model). The protective association with marriage
appears to be most pronounced among those classified as ‘other’ race. Those who were
divorced/separated had a corresponding hazard ratio of 1.64 (95% CI 1.32-2.02) compared to
their married counterparts, a marked departure from that of 1.29 (95% CI 1.23-1.36) observed
in the full population. Single patients in the ‘other’ race category (HR=1.55, 95% CI 1.28-1.87)
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also experienced higher risk relative to married patients compared to the same measure in the
full model (HR=1.33, 95% CI=1.27-1.39). For effect size estimates in the models stratified by
race, the confidence intervals were wider and the corresponding p-values were larger, although
each hazard ratio for the non-married categories across all 3 race strata remained statistically
significant.
Cervical Cancer and Survival
Among cervical cancer patients, unadjusted Kaplan-Meier survival analysis showed clear
differences in cancer-specific survival probabilities between the 4 marital status categories,
with married patients having the best survival, followed by single, divorced/separated, and
widowed patients respectively (Figure 7). The log-rank test for equality across strata was
significant (p<0.0001). Of the 2 739 cervical cancer patients who died of any malignant cancer
during follow-up, 1 021 (37.3%) were married, 462 (16.9%) were separated/divorced, 727
(26.5%) were single, and 529 (19.3%) were widowed. Of the 6 960 who were censored, 3 445
(50.0%) were married, 960 (13.8%) were separated/divorced, 1 916 (27.5%) were single, and
639 (9.2%) were widowed. After 36 months of post-diagnosis follow-up, cancer-specific
survival in this cohort was 78.8% among married, 69.1% among separated/divorced, 73.3%
among single, and 54.4% among widowed patients.
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Figure 7: Kaplan-Meier plot, cervical cancer patient survival, in months, stratified by marital
status, SEER cancer registries, 2004-2006 diagnoses
Among women diagnosed with invasive cervical cancer, being married at the time of
diagnosis was associated with lower risk of death from any cancer during follow-up compared
to those who were divorced/separated (HR=1.21, 95% CI 1.07-1.35), widowed (HR=1.32, 95% CI
1.16-1.50), and single (HR=1.19, 95% CI 1.07-1.31) (Table 11). Ecological variables substituted
as proxies for patient household income, education and Pap testing prevalence did not
meaningfully improve the model and weren’t included in the final version.
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Table 11: Multivariate Cox proportional hazards model for marital status and other variables
predicting death from any cancer among cervical cancer patients, SEER cancer registries, 20042006 diagnoses

There was no significant difference in risk of death among those age 40 and 49 years compared
to those younger than age 40 years (p=0.4123), but patients who were 50-59 (HR=1.24, 95% CI
1.09-1.41), 60-69 (HR=1.33. 95% CI 1.15-1.53), and older than age 70 years (HR=2.30, 95% CI
1.99-2.66) had increased risk of death compared to the youngest patients. Black patients with
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cervical cancer in this cohort had a higher risk of death from any cancer than whites (HR=1.27,
95% CI 1.14-1.41); there was no statistically significant difference between those classified as
‘other’ race and whites (p=0.1027). Women who lived outside metropolitan areas had slightly
higher risk of death during follow-up (HR=1.16, 95% CI 1.03-1.30). As was the case with
colorectal and female breast cancer patients, cervical cancer patients with regional (HR=4.98,
95% CI 4.42-5.60) and distant stage disease (HR=19.03, 95% CI 16.74-21.65) had substantially
higher risk of death from any cancer during the follow-up period.
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CHAPTER 5
DISCUSSION
Primary Findings
In this population-based study, married patients with colorectal, breast, and cervical
cancer experienced better cancer-related outcomes than those who weren’t married. These
findings have certain limitations, but this much is clear: 1) married adults with colorectal,
breast, and cervical cancer (all of which can be detected early with routine screening) were
diagnosed at an earlier disease stage than their non-married counterparts, and 2) even after
controlling for stage and important demographic factors, married patients experienced better
all-cancer survival than those who were divorced/separated, widowed, or single.
Within the 3 non-married groups, differences existed in cancer stage distribution and
survival, but the disparity between the 2 broader groups (married and non-married) was
remarkably consistent across each of the 3 anatomic cancer sites and multiple levels of analysis.
Even with limited information about the screening and treatment behaviors of the patients in
these 3 cohorts, unmarried adults are a subset of the population that may stand to benefit from
targeted prevention or care initiatives throughout the natural course of preventable and/or
detectable cancers. Given the consistently protective association between marriage and
superior cancer outcomes observed in this study, researchers focusing on patients with 1 of
these 3 cancers should consider marital status as a meaningful determinant of stage at
diagnosis and cancer-specific survival. In the meantime, additional research examining the
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mechanisms underlying the association between marriage and cancer-specific survival in
patients diagnosed with these 3 cancers is important.
Distant Stage Cancer at Diagnosis
In looking at colorectal and female breast cancer stage at diagnosis outcomes, the
protective association among those who were married compared to that of patients in the 3
non-married groups was consistently stronger for the distant vs. localized than for the regional
vs. localized stage comparisons (Tables 6 and 7). The same was true in the stratified analyses
(Appendices A and B), with the protective association especially pronounced among the male
colorectal cancer patients. This was not the case among cervical cancer patients, with the
exception of those in the single (never married) group (Table 8). It is possible that differences
in social network support may explain some of variation in the associations. For example,
perhaps less adherence (e.g. lower prevalence or frequency of screening) to early detection
guidance for colorectal and breast cancer in the 3 non-married groups could result in discovery
at a later stage disease by virtue of clinical symptomatology. The result would be a stronger net
protective effect of marriage through its influence on the use of clinical preventive services.
The largest difference observed in the regional/distant vs. localized comparisons was among
single patients. This was true for all 3 cancer sites (and was the only of the non-married
categories to have a stronger distant vs. localized comparison within the cervical cancer
cohort). Those who have never been married may be less likely to have some of the residual
familial support network (e.g. adult children, or lasting friendships developed with or through
an ex-spouse, etc.) enjoyed by those in the divorced/separated and widowed groups. Smaller
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support networks could result in lower overall levels of external encouragement to adhere to
recommended early detection schedules for these cancers. In cancers that can potentially be
detected early, stage at diagnosis data are often evaluated within the context of population
screening rates broken down by variable(s) of interest. According to the most recent Centers
for Disease Control and Prevention (CDC) data linked to USPSTF guidelines, non-married
(divorced/separated, widowed, and single) individuals are more likely to fail to meet guidelines
for colorectal, breast, and cervical cancer screening compared to those who are currently
married.61 In 2010, 62.9% of married adults were up-to-date with USPSTF guidelines for
colorectal cancer screening, compared to 54.1% of divorced/separated, 54.7% of widowed, and
49.6% of single men and women. Similar differences were reported among women screening
for breast and cervical cancers. Greater than 76% of married women were meeting USPSTF
guidelines for breast cancer screening in 2010, compared to 63.7% of divorced/separated,
71.8% of widowed, and 66.1% of single women. Nearly 86% of married women were current
with USPSTF guidance for cervical cancer guidance during the same time period, compared to
81.3% of divorced/separated, 78.0% of widowed, and 77.2% of single women.61 These CDC
data were derived from a nationally population-based representative sample from the SEER
registries although the data did not incorporate the entire U.S. population. With this in mind,
the marked differences in national cancer screening rates between married and non-married
individuals are still consistent with the findings in the current study that non-married colorectal,
breast, and cervical cancer patients tend to be diagnosed with later stage disease compared to
married counterparts.
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Interestingly, among breast cancer patients, advancing age was increasingly protective
in older age women, who had a lower likelihood of regional compared to localized disease.
There was essentially no age trend in associations for the distant vs. localized comparison. This
was not the case among cervical cancer patients, where increased age was a risk factor for later
tumor stage at diagnosis, with an increase in likelihood of both regional and distant stage
disease from the youngest to the oldest age groups. One potential explanation for this finding
among breast cancer patients could be that the younger women in this cohort may be more
likely than older women to have genetic mutations predisposing them to more aggressive types
of breast cancer than their older counterparts. Research has found that younger women with
breast cancer are more frequently diagnosed with non-localized disease and their tumors may
be more likely to show characteristics unfavorable to prognosis.62 However, this hypothesis is
complicated by the absence of the same trend among those diagnosed with distant stage
disease, but it’s possible that breast cancers associated with certain mutations in younger
women may be more frequently discovered (through mammography or clinical exam) at the
regional stage.
Among colorectal cancer patients, a similar, though less pronounced trend was
observed with advancing age in the distant vs. localized stage comparison although the same
association was not seen for age and regional vs. localized disease, which was null or close to
null. However, for the distant vs. localized comparison, women 70 years of age or older had
greater than 20% lower likelihood of distant stage disease than those in the youngest age group
(OR=0.79, 95% CI 0.75-0.84 and OR=0.78, 95% CI=0.73-0.82 for 70-79 year-olds and 80+ yearolds respectively). One potential explanation for this finding may be that older individuals who
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perceive that they are at risk for colorectal cancer based on personal history or familial risk
factors are more likely to pursue gold-standard screening, such as colonoscopy, to catch this
disease early. Research has shown that younger individuals are more likely to be diagnosed
with less differentiated and later stage colorectal cancer, which may be partially attributed to
higher rates of screening in older age groups.5 Colonoscopies are expensive procedures, but
Medicare began covering them for average-risk beneficiaries in 2001, whereas previously
coverage had been limited to those who were deemed high-risk.63 Removal of a substantial
cost barrier, and the subsequent effect on screening behavior, could have increased the
likelihood that those old enough to qualify for this benefit generally detect the disease at an
earlier stage. It is unclear what could be influencing the difference in the protective
associations of age for the regional and distant stage comparisons, but it may be worth
examining differences in primary tumor site and histology to see if variations in these factors
are disproportionately associated with either younger or older patients.
Black patients had had 25% higher likelihood of distant vs. localized stage disease at
diagnosis compared to whites and those classified as ‘other’ race. In part because of historically
high rates of disease and death, colorectal cancer awareness has been heavily promoted within
African American communities in the United States in recent years; research published just
prior to the period when patients in this cohort were diagnosed found that blacks were actually
more likely to be current with colorectal cancer screening guidelines than whites.64 However,
blacks are still more likely than whites to be diagnosed with advanced stage colorectal cancer,
but disparities in anatomic sub-site (e.g. proximal vs. distal disease) of diagnosis and potential
differences in tumor aggressiveness by race render it difficult to disentangle truly independent
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effects of screening, race, genetics, and exposures on differential outcomes in stage at
diagnosis.65 Black female breast cancer patients were more likely than those of other races to
have regional and distant stage disease at the time of diagnosis. Researchers have long held
that black women are more likely than whites to be diagnosed with late stage breast cancer.66
Factors beyond racial differences in mammography screening rates likely influence this
disparity; some of the most notable possibilities include socioeconomic status, lifestyle factors,
and biologic tumor characteristics.67
Survival Following Cancer Diagnosis
In unadjusted analysis, widowed colorectal cancer patients experienced the lowest 3year survival of all the marital status categories, but single patients had the largest
corresponding hazard ratio in the adjusted Cox proportional hazards model (Table 9). It is
difficult to make direct comparisons between the findings of our study and the results from
past studies. In prior studies researchers only considered colon cancer,38,43 conducted their
work in foreign countries with considerably different health care systems,42 or published their
findings decades ago.41 Also, there were differences in how the outcome ‘event’ of interest
(e.g. death from one cancer, death from any cancer, death from any cause, etc.) was defined.
These variations could limit the comparability of the effect sizes determined by using survival
analyses. Keeping these limitations in mind, it is valuable to compare the findings of the
current study with those of past related research studies in order to consider consistencies,
discrepancies, and potential strategies to improve the validity of this type of outcomes
research.
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Within the United States, colon cancer is far more prevalent than rectal cancer, and the
hazard ratio for colorectal cancer patients who are single (HR=1.30, 95% CI 1.25-1.35) was
slightly larger than that observed in colon cancer patients in Lai’s study (HR=1.23, 95% CI 1.181.29) although the association was in the same direction and of similar magnitude.43
Interestingly, the patients in the other non-married categories (divorced, separated, widowed)
in Lai’s study had hazard ratios closer to the referent (married patients) than did non-married
patients in the cohort analyzed for the current study. The difference between risk of death in
other non-married patient categories in Lai’s cohort (HR range: 1.11-1.15) and the same
categories in the current study (HR range 1.24-1.29) is meaningful when one considers the
number of total cases of colorectal cancer (more than 133 000 diagnosed in the United States
each year).4 The true difference in risk of death by marital status may be slightly larger in rectal
cancer patients than colon cancer patients, which could mean Lai’s technique of treating the
two as distinct tumors during analysis may mask some of the actual risk present in the broader
patient population, but this would be difficult to determine without further stratification and
analysis. Results from Goodwin’s study, however, do not support the idea that marital status is
more protective among rectal compared to colon cancer patients, although the methods are
not entirely analogous. Their results do not display effect sizes for specific tumors by nonmarried subgroups, but rather present them as unmarried vs. married. These do show higher
risk of nonlocal disease and failure to receive treatment among unmarried rectal compared to
colon cancer patients, but the relative risk of dying is lower in unmarried rectal cancer patients
after controlling for disease stage and receipt of treatment (RR=0.97, 95% CI 0.84-1.28 in rectal
cancer patients, RR=1.27, 95% CI 1.11-1.45 in colon cancer patients).41 The current study does
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not consider receipt of definitive treatment which would have been difficult to define across
each of the 3 tumor types and multiple years. On the other hand, Goodwin et al controlled for
this factor which could influence their final effect size estimations.
Wang et al used single patients as the referent in their Cox proportional hazards model
and found that married patients were 14% less likely (HR 0.86, 95% CI 0.82-0.90) to die from
cancer than those who were single. They used a similar definition for the event of interest
(death from any cancer), which should enhance the comparability of results. However, only
colon cancer patients were considered, and they were also able to control for receipt of cancerdirected surgery.38 Other researchers studying cancer-specific survival have suggested that
never-married (single) men’s higher likelihood of substance abuse and risky behaviors may
result in an increased prevalence of comorbidities relative to women, which could negatively
influence health status as well as disease progression.39 After stratifying by sex, the
proportional hazards model in Appendix C provided some support for this hypothesis, with an
elevated hazard ratio in single men (relative to other non-married groups) while the hazard
ratio in women was essentially identical across the 3 non-married groups. Methodological
differences notwithstanding, the existence of a clear protective association between marriage
and survival after colorectal cancer diagnosis, even after controlling for tumor stage, is
consistent between the current study and those done in the past. The effect of ‘receipt of
definitive surgery’ as a potential confounder is not entirely known, but results of the current
study suggest the effect of marriage on survival may be slightly more pronounced than has
been previously reported, further emphasizing the importance of expanded research into the
behavioral or immunologic mechanisms influencing this phenomenon.
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As was the case with colorectal cancer patients, widowed female breast cancer patients
experienced the lowest 3-year cancer-specific survival during unadjusted analysis, but those
who were single had the largest corresponding hazard ratio in proportional hazards analysis
(HR=1.33, 95% CI 1.27-1.39), during which age, race, and cancer stage were controlled. Effect
sizes across the 3 non-married categories (divorced/separated, widowed, single) were nearly
identical (HR range: 1.29-1.33), potentially lending support to a hypothesis that the
mechanisms influencing marriage’s association with survival in breast cancer patients may
equally induce a protective effect regardless of the particular way an individual enters (or
remains in) the non-married state. Among those classified as ‘other’ race, divorced/separated,
and single patients, but not those who were reported as widowed, had markedly higher risk of
cancer-specific death during follow-up than that which was observed in the full model. The
reason widowed patients did not also experience higher risk of death during follow-up is
unclear, but it could mean that among certain racial minorities, widowed individuals are more
likely to have either the self-efficacy and/or support network necessary to make it more likely
that they will pursue aggressive cancer-directed treatment. Age was controlled for in the
regression models, so it is unlikely that differences in age distribution between those who were
widowed and others had any influence on the relatively superior outcomes of the widowed
patients under these specific circumstances.
During unadjusted analysis, widowed cervical cancer patients had substantially lower 3year cancer-specific survival than those who were married (54.4% vs. 78.8% respectively), the
largest survival difference between married patients and a non-married group for any of the 3
cohorts. In Cox proportional hazards analysis, widowed patients retained the highest risk of
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cancer-specific death during follow-up even after adjusting for confounders; this was the only
instance among the 3 cohorts when the group with the poorest survival during unadjusted
analysis also had the largest corresponding hazard ratio in the Cox model. Research has shown
that widowed women are less likely than married, cohabitating, divorced/separated, and single
women to report being up-to-date with Pap testing.29 Controlling for disease stage likely
accounts for some of the survival difference attributable to disparities in cervical cancer
screening; receipt of definitive treatment was not controlled for in the current study. However,
if widowed women are less likely to stay current with appropriate preventive guidelines, they
may also be less likely to seek and receive cervical cancer treatment, or they may not address
their disease as aggressively as those in other marital status categories. In a study of factors
associated with untreated cervical cancer in the United States, patients who were unmarried
and older were less likely to receive any treatment following their diagnosis.68 Other
researchers have found that older patients were more likely to eschew treatment altogether or
choose less aggressive treatment options.69 While the current study controlled for age, it’s
clear that widowed patients have the oldest age distribution (Table 5), with more than 55%
falling into the 70 years of age or older category. If old age is indeed associated with a lower
likelihood of receiving appropriate cancer-directed treatment, then widowed patients in this
SEER cohort may not be receiving the level of post-diagnostic care enjoyed by those in other
marital status categories. The distinct age/hazard gradient observed in Table 11 suggests that
even while controlling for other factors, advanced age is still associated with a lower likelihood
of survival following cervical cancer diagnosis. While on the surface this may not appear to be a
very surprising finding, Coker et al suggest that there is still controversy over whether age is
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associated with survival after controlling for relevant confounders.69 The protective effect of
younger age, even after controlling for stage and race, was consistent with the general findings
reported by Coker, although they also controlled for receipt of cancer-directed treatment.
The observational, retrospective nature of the current study prohibits definitive
conclusions on whether the differences in survival between married and non-married patients
were a result of patient health before the development of cancer, patient post-diagnosis
behavior related to clinical decisions and familial interactions, immunologic differences, or
some combination of these factors. A logical next step to begin addressing this question could
be to define ‘best practices’ in cancer-directed treatment during the time period in which these
patients were diagnosed and followed (2004 through 2009), and determine whether being
married influenced the likelihood of patients in the 3 tumor cohorts receiving appropriate
therapy.
Proponents of the selection effect commonly emphasize that healthier individuals may
be more fit (and desirable) for marriage in the first place, which could account for some of the
observed survival advantage among married patients.38 Kaplan et al suggested that lower
survival in the never married compared to the divorced/separated and widowed may provide
evidence supporting the presence of this effect, because never entering marriage may increase
the likelihood for more severe social isolation and reduced social connectedness.47 In the
current study, the never married (single) patients had lower adjusted survival than the
divorced/separated and widowed for 2 of the 3 cancer patient cohorts (colorectal and female
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breast), although the differences in effect sizes were not very pronounced. Single patients had
the longest adjusted survival of the 3 non-married groups in the cervical cancer cohort.
Further consideration raises an interesting prospect, however, in that it’s clear that the
selection effect and the social causation effect, 2 of the leading theories proposed to explain
the protective health effect of marriage, usually cannot be totally disentangled. While the
selection effect may limit the marriage prospects of less healthy individuals (resulting in fewer
‘unfit’ individuals getting married), the relative deficiency of social networks in those left out of
marriage is likely to exacerbate the disparity in health outcomes between the 2 groups. It
seems likely that the presence or absence of one effect in combination with the other could
modify the cumulative impact on health incomes. If there does prove to be a larger negative
effect on cancer survival in never-married individuals, then it could be worthwhile to
investigate the potential mediating factors, because recent research on all combined types in a
European cancer patient population suggests that the excess mortality in single compared to
married individuals has increased in recent years, especially among men, while the excess
mortality observed in divorced/separated men and women has remained stable.70 While the
aforementioned research was conducted in a country with universal access to healthcare, as
well as different societal norms for marriage, increasing health outcome disparities between
the single and the previously-married could be an early indication of reduced society-level
cohesion, which may leave single individuals especially vulnerable due to limited social support
networks. The current study does not compare survival estimates across time, so from these
data it is impossible to know whether a similar trend of excess never-married mortality is
occurring in patients diagnosed with these cancers in the United States.
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The findings in the current study that non-married cancer patients were diagnosed at
later disease stage, and subsequently (while controlling for age) had poorer survival than
married counterparts, fits with components of the social causation theory, although we can’t
know how much of the effect sizes are attributable to this factor. Enhanced social networks
present during married life may positively influence decisions related to physical activity, diet,
tobacco and alcohol use, and health-seeking behaviors, all of which influence tumor
development and/or cancer prognosis.71 Children from a current (or previous) marriage may
also play a positive role in helping elders navigate the health care system.70
Others who have researched social support networks’ potential to serve as ‘stress
buffers’ through the effects of natural killer cells (cytotoxic cells of the immune system that
respond to tumor growth) have suggested that social support also boosts the body’s ability to
fight the disease. Levy et al found that a substantial amount of the variance in natural killer cell
activity in 25 to 70 year old women diagnosed with localized and regional stage breast cancer
was explained by the presence or absence of quality emotional support from a spouse or
intimate partner.72 Cortisol, a reliable measure of physiologic stress, which has been shown to
accelerate tumor cell growth in humans, has also been studied as a potential pathway for the
influence of social support on cancer survival. The clinical implications are not entirely clear,
but among women with distant stage breast cancer, those reporting stronger social support
(based on size and quality of networks) had lower mean salivary cortisol levels, likely an
indication of better neuroendocrine functioning.73 While stress associated with limited social
support networks may or may not have any influence on the initial development of a tumor, it
appears that there are plausible pathways through which the presence of support in a time of
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need may serve to diminish or blunt the influences of endocrine system changes associated
with tumor cell proliferation.71
Limitations
There are certain limitations that should be considered while interpreting these results.
Enhanced availability of patient-level information would increase the potential to draw more
definitive conclusions from the findings in each of the 3 cancer patient cohorts. The SEER
registry data do not provide individual-level socioeconomic variables, such as personal or
household income, educational attainment, or occupational class. Ecological variables may
serve as proxies for these variables, an approach others have implemented in similar studies,
but this method increases the potential for bias.39,40,43,74 Nonetheless, ecological variables for
income, education, and select cancer screening behaviors were considered during the
formative stages of analysis for this study and they did not meaningfully contribute to the
explanatory models and therefore were excluded from the final versions presented in the
tables in this document. Information on personal medical history, comorbidities and insurance
status would also be extremely useful, but these variables were not available in the dataset. A
SEER-Medicare data linkage exists that could provide a richer collection of patient-level
information for patients who were Medicare enrollees. The Medicare files also contain records
on matched ‘non-cancer’ enrollees who can be included in analysis for comparative purposes.
Collectively, these linked datasets constitute one of the only domestic resources making it
possible to incorporate quality of cancer care measures into population-based research.75
However, the costs and administrative logistics associated with acquiring these additional data
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for the current study proved to be prohibitive. In the future, augmenting these analyses with
Medicare data may help address certain concerns associated with confounding and effect
modification related to medical history and comorbidities, although eligibility for--and
inferences from--such a study would be restricted to those older than age 65 years at the time
of diagnosis (with rare exceptions).
The current study did not control for receipt of definitive treatment. Although other
researchers have taken this approach to address potential confounders, their work usually
focused on a single tumor type.31,38 The complexities associated with determining treatment
best practices (e.g. surgery, radiation, chemotherapy, etc.) for different cancer types when
there is limited information available on individual medical history and tumor characteristics,
combined with the dynamic nature of what is considered ‘best practice’ for a specific condition,
influenced the decision to exclude this as a covariate in the current study. If the association
between marital status and cancer outcomes is investigated further for any of these 3 cancer
types individually, it might be more feasible and would be useful to assess what is considered
best practice treatment during the study period and incorporate that variable into multiple
regression models.
An additional limitation is the lack of information related to marital transitions (e.g.
divorce, widowing, and marriage) that occur after the baseline status measurement but prior to
the end of the follow-up period. The recorded value of the primary predictor variable does not
vary with time in this study, even if the patient undergoes a marital transition. However, given
that most of these patients are relatively advanced in age, it’s likely that the majority of the
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marital transitions in these cohorts would be in the direction of widowhood, or perhaps to a
lesser extent, divorce or separation.38 Assuming that there is such misclassification and that the
findings in the current study are accurate, then the true size of marriage’s protective effect
would be underestimated. Research has suggested that failure to update patient marital status
in longitudinal studies of its association with health outcomes does actually diminish the effect
size observed in statistical analysis.76
Another important issue to consider is a lack of information on the actual quality of any
given marriage for patients in this dataset. If social support is one of the mechanisms
moderating the positive association between marriage and these cancer outcomes, then there
is the assumption that support offered within the context of a marriage generally has positive
health effects. Patients in healthy relationships are more capable of averting depression
associated with a cancer diagnosis than those in relationships regarded as less emotionally
healthy; this can mean detrimental effects on health-related quality of life (for both partners)
for those in lower quality marriages.11,77 For those individuals in a marriage with pre-existing
high levels of stress, strife, or depression, the net negative influence of these factors may
negate any positive effects resulting from social support inherent to a marriage. Future studies
that are able to incorporate some validated measure to assess self-reported quality of marriage
may be able to better address this concern.
SEER is an observational database; in the current study it was possible to assess
associations between proposed risk factors and late stage disease/risk of death, but it was not
feasible to make conclusions about the causal nature or directionality of observed correlations.
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Simply put, it is impossible to say with any certainty whether being unmarried causes inferior
colorectal, breast, and cervical cancer outcomes. It can only be stated that being unmarried is
associated with these outcomes, and then provide evidence supporting the existence of
plausible causal mechanisms involved in these associations.
Cancer-specific survival was the primary outcome measure used in this study.
Determining the appropriate method for defining patient failure in survival analysis can be
difficult.53 One argument against using cause-specific survival is the potential for
misclassification of the cause of death, which could bias survival estimates.78 While
acknowledging the potential for this problem in the current study, research has found SEER
registry cause of death designations to be highly accurate and death from any cancer (as
opposed to tumor-specific) to be an appropriate survival measure in older patient populations
with a relatively high risk of death from competing non-cancer conditions, which would not be
censored in analysis assessing overall survival.60
Conclusions
The association between marital status and health outcomes is complex, and it is likely
that whether an individual is married or not can affect health, and in turn be affected by it.79
Research that does not acknowledge and investigate this complex relationship could result in
erroneous results and lead to faulty conclusions regarding the influence of marriage on health.
There is broad public and scientific interest in determining whether social factors such as
marriage influence the development or progression of cancer.71 Researchers have long held
that marriage is favorably associated with health, with most acknowledging some combination
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of selection and social causation effects as the primary drivers of the beneficial
association.41,79,80 Goodwin and colleagues are generally credited with first identifying a
protective effect of marriage on survival in cancer patients.39 However, much of the research
on this topic has been devoted to cancers for which there are no proven early detection
methods recommended for average-risk adults.11,13,31,39,40,74,81 Based on a review of the
literature, the current study appears to be the first in which this relationship has been assessed
in a contemporary United States population for the 3 cancers with definitive screening
recommendations. If differing forms of social causation play a role in the protective
associations observed in current study, then it’s likely that we as a society can reduce this
disparity through tailored interventions and educational programs. While these data do not
allow for conclusions on causal mechanisms, simply knowing that the presence or absence of
marriage can have a substantial impact on cancer-specific survival at the population level could
serve as a motivator for action.
There are numerous factors influencing the association between marriage and cancer
outcomes. These may include substance abuse, diet, physical activity, insurance status, mental
health, and hospital care. Because this study focused on cancers detectable through routine
screening, these data coupled with complementary behavioral research may be most useful
when viewed through the lens of preventive health services’ influence on the marital
status/cancer relationship. In a comprehensive literature review of the effects of marriage on
general health, Wood et al found limited research on relationships between marital status and
utilization of preventive health services.79 While there are no nationally representative data
connecting marital transitions and changes in the use of cancer-related preventive services, Lee
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at al found that among female nurses age 46 to 71 who had received a mammogram during the
previous 2 years, transitions out of marriage (widowing or divorce) were associated with an
approximately 25% higher likelihood of women skipping regular breast cancer screening during
the next 4 years (adjusted OR=1.27, 95% CI 0.94-1.73 in divorced, OR=1.24, 95% CI 1.07-1.44 in
widowed).82 Interestingly, remarrying did not alter the already lower likelihood that these
women would skip routine breast cancer screening in the near future. This finding suggests
that the likelihood of screening for cancer may not simply be associated with getting and
staying married, but also (or perhaps, rather) with the presence or absence of anguish or stress
resulting from the loss of a spouse or partner. Wood’s contemporary literature review of the
topic suggests that there is some support for this theory in research focused on other types of
cancer screening, but most other methodologies are cross-sectional and/or descriptive. They
conclude by calling for an expansion of the representativeness of research on marital status and
use of cancer-related preventive services.79 While the results of the current study certainly
enhance our ability to characterize the disparity in outcomes between married and the nonmarried colorectal, breast, and cervical cancer patients, additional person-level information on
use of preventive services as well as other important variables could certainly solidify our
understanding of the issue, and improve our ability to find actionable items in the causal
pathway(s) for future research, policy and interventions.
Ongoing implementation of healthcare reform creates an opportunity for public health
to enhance its role as a national leader in cancer prevention and control. Screening for
colorectal, breast, and cervical cancer saves lives, but there are still disparities in the uptake of
clinical preventive health services. There has been no improvement in national rates of
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screening for breast and cervical cancer during the last decade, and scarcely more than half of
adults adhere to recommended colorectal cancer screening guidelines.23,83 While the current
study does not account for differences in screening rates, we know that within this population,
non-married adults are generally diagnosed with later stage cancer and have shorter survival,
suggesting that early detection plays a role. The Patient Protection and Affordable Care Act will
address traditional barriers such as lack of insurance through expansion of social safety nets for
the poor and subsidized insurance exchanges for those in the working class, but
complementary initiatives could target those who still do not actively pursue clinical preventive
services.83 The limitations of the current study may actually highlight opportunities for
improvements in the infrastructure of cancer prevention. Currently, the best data available on
the prevalence of cancer screening in the United States come from self-reported telephonebased surveys administered regularly over time. Registries such as SEER, however,
comprehensively document events (in SEER’s case, cancer outcomes) as they occur. With the
substantial expansion of insurance coverage promised by health reform, there may be an
opportunity to link Medicare, Medicaid, state insurance exchange, and other health benefits
data to monitor preventive health behavior comprehensively at the individual level, and in real
time. Special populations with poor health outcomes (such as non-married adults within the
age range for cancer screening) might benefit from targeted programs designed to improve
screening uptake and clinical follow-up while also monitoring treatment decisions and cancerspecific outcomes.

96

REFERENCES

1) Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.

2) National Cancer Institute. Cancer screening overview (PDQ).
http://cancer.gov/cancertopics/pdq/screening/overview/patient. Accessed October 10, 2012.

3) Eheman C, Henley SJ, Ballard‐Barbash R, et al. Annual report to the nation on the status of
cancer, 1975‐2008, featuring cancers associated with excess weight and lack of sufficient
physical activity. Cancer. 2012;118(9):2338-2366.

4) United States Department of Health and Human Services, Centers for Disease Control and
Prevention and National Cancer Institute. U.S. Cancer Statistics: 1999-2009 Incidence, WONDER
Online Database. http://wonder.cdc.gov/cancer-v2009.html. Accessed March 14, 2013.

5) Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer,
1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors,
screening, and treatment) to reduce future rates. Cancer. 2009;116(3):544-573.

6) United States Department of Health and Human Services, Centers for Disease Control and
Prevention. U.S. Cancer Statistics: 1999 - 2009 Mortality, WONDER Online Database.
http://wonder.cdc.gov/CancerMort-v2009.html. Accessed March 14, 2013.

7) Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality
from breast cancer. N Engl J Med. 2005;353(17):1784-1792.

97

8) Blackley D, Zheng S, Ketchum W. Implementing a weighted spatial smoothing algorithm to
identify a lung cancer belt in the United States. Cancer Epidemiol. 2012;36:436-438.

9) Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic
status. CA Cancer J Clin. 2004;54:78-93.

10) Singh GK, Miller BA, Hankey BF, Edwards BK. Area Socioeconomic Variations in U.S. Cancer
Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. NCI Cancer Surveillance
Monograph Series, Number 4. Bethesda, MD: National Cancer Institute, 2003. NIH Publication
No. 03-5417.

11) Gore JL, Kwan L, Saigal CS, Litwin MS. Marriage and mortality in bladder carcinoma. Cancer.
2005;104(6):1188-1194.

12) Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2012. A review
of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer
J Clin. 2012;62:129-142.

13) Nelles JL, Joseph SA, Konety BR. The impact of marriage on bladder cancer mortality. Urol
Oncol. 2009;27(3):263-267.

14) Warner E, Jotkowitz A, Maimon N. Lung cancer screening–are we there yet? Eur J Intern
Med. 2010;21(1):6-11.

98

15) Lin SS, Clarke CA, Prehn AW, Glaser SL, West DW, O'Malley CD. Survival differences among
Asian subpopulations in the United States after prostate, colorectal, breast, and cervical
carcinomas. Cancer. 2002;94(4):1175-1182.

16) Jett JR, Midthun DE. Commentary: CT screening for lung cancer—caveat emptor.
Oncologist. 2008;13(4):439-444.

17) Price RA, Zapka J, Edwards H, Taplin SH. Organizational factors and the cancer screening
process. JNCI Monographs. 2010;2010(40):38-57.

18) U.S. Preventive Services Task Force. About the USPSTF: Introduction.
http://www.uspreventiveservicestaskforce.org/intro.htm. Accessed October 18, 2012.

19) Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.

20) Ries LAG, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer,
1973–1997, with a special section on colorectal cancer. Cancer. 2000;88(10):2398-2424.

21) U.S. Preventive Services Task Force. Screening for colorectal cancer, topic page.
http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Accessed December 10,
2012.

22) U.S. Department of Health and Human Services, Centers for Disease Control and
Prevention. Behavioral Risk Factor Surveillance System survey data.
http://apps.nccd.cdc.gov/brfss/. Accessed November 21, 2012.

99

23) Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal
cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
Cancer Epidemiol Biomarkers Prev. 2012;21(6):895-904.

24) van Jaarsveld CHM, Miles A, Edwards R, Wardle J. Marriage and cancer prevention: does
marital status and inviting both spouses together influence colorectal cancer screening
participation? J Med Screen. 2006;13(4):172-176.

25) Stimpson JP, Wilson FA, Watanabe-Galloway S, Peek MK. The effect of marriage on
utilization of colorectal endoscopy exam in the United States. Cancer Epidemiol. 2012;36:e325e332.

26) U.S. Preventive Services Task Force. Screening for breast cancer, topic page.
http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm. Accessed December 10,
2012.

27) Coughlin SS, King J, Richards TB, Ekwueme DU. Breast cancer screening and socioeconomic
status—35 metropolitan areas, 2000 and 2002. MMWR. 2005;54(39):981-985.

28) U.S. Preventive Services Task Force. Screening for cervical cancer, topic page.
http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed December 10,
2012.

29) Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in
metropolitan areas of the United States by individual-level and area-based measures of

100

socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev. 2006;15(11):21542159.

30) Hewitt M, Devesa SS, Breen N. Cervical cancer screening among US women: Analyses of the
2000 National Health Interview Survey. Prev Med. 2004;39(2):270-278.

31) Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in
pancreatic cancer patients: A SEER based analysis. PloS one. 2011;6(6):e21052.

32) Cherlin AJ. American marriage in the early twenty-first century. Future Child. 2005;15(2):3355.

33) Jaffe DH, Manor O, Eisenbach Z, Neumark YD. The protective effect of marriage on mortality
in a dynamic society. Ann Epidemiol. 2007;17(7):540-547.

34) Parker K, Wang W, Morin R, Horowitz JM, Cohn D. The decline of marriage and rise of new
families. Pew Research Center; 2010. Taylor P, ed. Social and Demographic Trends Project.

35) Taylor P, Parker K, Cohn D, Passel JS, Livingston G, Wang W, et al. Barely half of U.S. adults
are married—a record low. Pew Research Center; 2011. Taylor P, ed. Social and Demographic
Trends Project.
36) H.R. 3734—104th Congress: Personal Responsibility and Work Opportunity Reconciliation
Act of 1996. August 22,1996;Public Law 104-193.
http://www.govtrack.us/congress/bills/104/hr3734. Accessed December 20, 2012.

101

37) Manzoli L, Villari P, Boccia A. Marital status and mortality in the elderly: A systematic review
and meta-analysis. Soc Sci Med. 2007;64(1):77.

38) Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status and colon cancer outcomes in
US Surveillance, Epidemiology and End Results registries: Does marriage affect cancer survival
by gender and stage? Cancer epidemiol. 2011;35(5):417-422.

39) Abdollah F, Sun M, Thuret R, et al. The effect of marital status on stage and survival of
prostate cancer patients treated with radical prostatectomy: A population-based study. Cancer
Cause Control. 2011;22(8):1085-1095.

40) Chang SM, Barker II FG. Marital status, treatment, and survival in patients with glioblastoma
multiforme. Cancer. 2005;104(9):1975-1984.

41) Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment,
and survival of cancer patients. JAMA-J Am Med Assoc. 1987;258(21):3125-3130.

42) Johansen C, Schou G, Soll-Johanning H, Mellemgaard A, Lynge E. Influence of marital status
on survival from colon and rectal cancer in Denmark. Br J Cancer. 1996;74(6):985.

43) Lai KC, Stotler BA. Marital status and colon cancer stage at diagnosis. Open Colorectal
Cancer J. 2010;3:5-11.

44) Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the
stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer
Res Treat. 2005;93(1):41-47.
102

45) Murphy M, Goldblatt P, Thornton-Jones H, Silcocks P. Survival among women with cancer of
the uterine cervix: influence of marital status and social class. J Epidemiol Community Health.
1990;44(4):293-296.

46) Patel MK, Patel DA, Lu M, Elshaikh MA, Munkarah A, Movsas B. Impact of marital status on
survival among women with invasive cervical cancer: analysis of population-based Surveillance,
Epidemiology, and End Results data. J Low Genit Tract Dis. 2010;14(4):329.

47) Kaplan RM, Kronick RG. Marital status and longevity in the United States population. J
Epidemiol Community Health. 2006;60(9):760-765.

48) National Cancer Institute, Surveillance, Epidemiology and End Results Program. About the
SEER program. http://seer.cancer.gov/about/. Accessed October 18, 2012.

49) Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al (eds). SEER
cancer statistics review, 1975-2009 (vintage 2009 populations), National Cancer Institute.
Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/. Accessed October16, 2012.

50) Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al (eds). International
Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health
Organization; 2000.

51) Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the
AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-1474.

103

52) National Institutes of Health, National Cancer Institute. SEER training modules.
http://training.seer.cancer.gov/staging/systems/. Accessed November 12, 2012.

53) Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of
cancer-specific survival rates from population-based data. J Natl Cancer Inst.
2010;102(20):1584-1598.

54) National Institutes of Health, National Cancer Institute. SEER research data record
description, cases diagnosed in 1973-2009.
http://seer.cancer.gov/data/seerstat/nov2011/TextData.FileDescription.pdf. Accessed
November 8, 2012.

55) Denberg TD, Beaty BL, Kim FJ, Steiner JF. Marriage and ethnicity predict treatment in
localized prostate carcinoma. Cancer. 2005;103(9):1819-1825.

56) Datta GD, Neville BA, Kawachi I, Datta NS, Earle CC. Marital status and survival following
bladder cancer. J Epidemiol Community Health. 2009;63(10):807-813.

57) Hellenthal NJ, Chamie K, Ramirez ML, White RWD. Sociodemographic factors associated
with nephrectomy in patients with metastatic renal cell carcinoma. J Urol. 2009;181(3):10131019.

58) Adamo MB, Johnson CH, Ruhl JL, Dickie, LA (eds.). 2012 SEER program coding and staging
manual. National Cancer Institute, NIH Publication number 12-5581:1-171, Bethesda, MD.

104

59) Surveillance Research Program, National Cancer Institute. County attributes.
http://seer.cancer.gov/seerstat/variables/countyattribs/. Accessed November 12, 2012.

60) Lund JL, Harlan LC, Yabroff KR, Warren JL. Should cause of death from the death certificate
be used to examine cancer-specific survival? A study of patients with distant stage disease.
Cancer Invest. 2010;28(7):758-764.

61) Centers for Disease Control and Prevention, National Center for Health Statistics. Health
Indicators Warehouse. www.healthindicators.gov. Accessed February 15, 2013.

62) Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young
women: poor survival despite intensive treatment. PLoS One. 2009;4(11):e7695.

63) Shih YT, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic
disparities in cancer screening among the elderly? Health Aff. 2006;25(4):1153-1162.

64) Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening
participation in the United States. Am J Gastroenterol. 2003;98(9):2082-2091.

65) Wu XC, Chen VW, Steele B, et al. Subsite‐specific incidence rate and stage of disease in
colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer.
2001;92(10):2547-2554.

66) Jones BA, Kasl SV, Curnen MG, Owens PH, Dubrow R. Can mammography screening explain
the race difference in stage at diagnosis of breast cancer? Cancer. 2006;75(8):2103-2113.

105

67) Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by
race and ethnicity. Arch Intern Med. 2003;163(1):49.

68) Trimble EL, Harlan LC, Clegg LX. Untreated cervical cancer in the United States. Gynecol
Oncol. 2005;96(2):271-277.

69) Coker AL, Du XL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival
among older women: Findings from the SEER–Medicare linked data cohorts. Gynecol Oncol.
2006;102(2):278-284.

70) Kravdal H, Syse A. Changes over time in the effect of marital status on cancer survival. BMC
Public Health. 2011;11(1):804.

71) Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: A metaanalysis. Crit Rev Oncol. 2010;75(2):122.

72) Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Perceived social support
and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in
breast cancer patients. Psychosom Med. 1990;52(1):73-85.

73) Turner-Cobb JM, Sephton SE, Koopman C, Blake-Mortimer J, Spiegel D. Social support and
salivary cortisol in women with metastatic breast cancer. Psychosom Med. 2000;62(3):337-345.

74) Ortiz CAR, Freeman JL, Kuo Y, Goodwin JS. The influence of marital status on stage at
diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci.
2007;62(8):892-898.
106

75) Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data:
Content, research applications, and generalizability to the United States elderly population.
Med Care. 2002;40(8):IV3-IV18.

76) Korenman S, Goldman N, Fu H. Misclassification bias in estimates of bereavement effects.
Am J Epidemiol. 1997;145(11):995-1002.

77) Nijboer C, Triemstra M, Tempelaar R, Sanderman R, van den Bos GAM. Determinants of
caregiving experiences and mental health of partners of cancer patients. Cancer.
2000;86(4):577-588.

78) Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs
cancer-specific survival. Int J Epidemiol. 2010;39(2):598-610.

79) Wood RG, Avellar S, Goesling B. (2007) The effects of marriage on health: A synthesis of
recent research evidence.Washington, DC: U.S. Department of Health and Human Resources

80) Berkson J. Mortality and marital status--reflections on the derivation of etiology from
statistics. Am J Public Health. 1962;52:1318-1329.

81) Abern MR, Dude AM, Coogan CL. Marital status independently predicts testis cancer
survival—an analysis of the SEER database. . 2012;30(4):487-493.

82) Lee S, Cho E, Grodstein F, Kawachi I, Hu FB, Colditz GA. Effects of marital transitions on
changes in dietary and other health behaviours in US women. Int J Epidemiol. 2005;34(1):69-78.

107

83) Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA
Cancer J Clin. 2012;62(4):217-219.

108

APPENDICES

APPENDIX A

Assessing Sex as an Effect Modifier of Stage at Diagnosis in Colorectal Cancer Patients

Baseline category logit analysis of marital status and other factors predicting colorectal cancer
stage at diagnosis in male patients, SEER cancer registries, 2004 through 2006 diagnoses,
n=47 524
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Baseline category logit analysis of marital status and other factors predicting colorectal cancer
stage at diagnosis in female patients, SEER cancer registries, 2004 through 2006 diagnoses,
n=45 181
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APPENDIX B

Assessing Race as an Effect Modifier of Stage at Diagnosis in Female Breast Cancer Patients
Baseline category logit analysis of marital status and other factors predicting female breast
cancer stage at diagnosis in white patients, SEER cancer registries, 2004-2006 diagnoses,
n=117 907
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Baseline category logit analysis of marital status and other factors predicting female breast
cancer stage at diagnosis in black patients, SEER cancer registries, 2004-2006 diagnoses,
n=13 677
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Baseline category logit analysis of marital status and other factors predicting female breast
cancer stage at diagnosis in patients classified as ‘other’ race, SEER cancer registries, 2004-2006
diagnoses, n=9 977
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APPENDIX C

Assessing Sex as an Effect Modifier of Survival in Colorectal Cancer Patients
Multivariate Cox proportional hazards model for marital status and other variables predicting
death from any cancer among male colorectal cancer patients, SEER cancer registries, 20042006 diagnoses, n=47 524
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Multivariate Cox proportional hazards model for marital status and other variables predicting
death from any cancer among female colorectal cancer patients, SEER cancer registries, 20042006 diagnoses, n=45 183
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APPENDIX D

Assessing Race as an Effect Modifier of Survival in Female Breast Cancer Patients
Multivariate Cox proportional hazards model for marital status and other variables predicting
death from any cancer among white female breast cancer patients, SEER cancer registries,
2004-2006 diagnoses, n=117 907
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Multivariate Cox proportional hazards model for marital status and other variables predicting
death from any cancer among black female breast cancer patients, SEER cancer registries, 20042006 diagnoses, n=13 677
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Multivariate Cox proportional hazards model for marital status and other variables predicting
death from any cancer among female breast cancer patients classified as ‘other’ race, SEER
cancer registries, 2004-2006 diagnoses, n=9 977
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